|
1 |
BNP |
NA: NA |
risk factor (article mentioned) |
|
2 |
SV |
NA: NA |
risk factor (article mentioned) |
|
12 |
non-Hispanic white |
NA: NA |
risk factor |
|
13 |
experiencing operating room (OR) time greater than 4 hours |
NA: NA |
risk factor |
|
14 |
having oxygen saturation levels less than 85% |
NA: NA |
risk factor |
|
15 |
average worse Braden QD scores per day |
NA: NA |
risk factor |
|
20 |
eduction (associate degree or higher) |
isolated CHD/non-isolated CHD: TAPVR/ASD/VSD/AVSD/CoA/TGA/ccTGA/CACA/DORV, DILV/EA/PDA/PVD/TA/TOF/other |
risk factor |
|
49 |
poor sleep combined with daytime nap (simple CHD offspring) |
isolated CHD: ASD/VSD/PDA/PVS/AVS/CoA/PAS |
risk factor |
|
50 |
poor sleep without daytime nap (simple CHD offspring) |
isolated CHD: ASD/VSD/PDA/PVS/AVS/CoA/PAS |
risk factor |
|
52 |
poor sleep combined with daytime nap (severe CHD offspring) |
isolated CHD: DORV/TGA/AVSD/TOF/HLHS/SV/TAPVR/TS |
risk factor |
|
53 |
poor sleep without daytime nap(severe CHD offspring) |
isolated CHD: DORV/TGA/AVSD/TOF/HLHS/SV/TAPVR/TS |
risk factor |
|
54 |
Arterial hypertension (percent) |
isolated CHD: AVD/PV/ASD/VSD/Ductus/other SAS/SVAS/CoA/Subvalvular or supravalvula PS/TOF/EA/AVSD/Sinus venosus SD/D-TGA/L-TGA/PA/SV/DORV/ES/TA/TAS |
risk factor(crude OR) |
|
58 |
Arterial hypertension (percent) |
isolated CHD: AVD/PV/ASD/VSD/Ductus/other SAS/SVAS/CoA/Subvalvular or supravalvula PS/TOF/EA/AVSD/Sinus venosus SD/D-TGA/L-TGA/PA/SV/DORV/ES/TA/TAS |
risk factor(article mentioned) |
|
59 |
Diabetes mellitus(percent) |
isolated CHD: AVD/PV/ASD/VSD/Ductus/other SAS/SVAS/CoA/Subvalvular or supravalvula PS/TOF/EA/AVSD/Sinus venosus SD/D-TGA/L-TGA/PA/SV/DORV/ES/TA/TAS |
risk factor(article mentioned) |
|
60 |
Dyslipidemia |
isolated CHD: AVD/PV/ASD/VSD/Ductus/other SAS/SVAS/CoA/Subvalvular or supravalvula PS/TOF/EA/AVSD/Sinus venosus SD/D-TGA/L-TGA/PA/SV/DORV/ES/TA/TAS |
risk factor(article mentioned) |
|
61 |
Smoking |
isolated CHD: AVD/PV/ASD/VSD/Ductus/other SAS/SVAS/CoA/Subvalvular or supravalvula PS/TOF/EA/AVSD/Sinus venosus SD/D-TGA/L-TGA/PA/SV/DORV/ES/TA/TAS |
risk factor(article mentioned) |
|
62 |
Chronic coronary artery disease: HR for cancer |
NA: NA |
risk factor |
|
63 |
Previous transplantationa status: HR for cancer |
NA: NA |
risk factor |
|
64 |
Chronic coronary artery disease: HR for all-cause mortality |
NA: NA |
risk factor |
|
65 |
Previous transplantationa status: HR for all-cause mortality |
NA: NA |
risk factor |
|
66 |
outcome of severe maternal morbidity |
: |
risk factor |
|
70 |
outcome of ischemic placental disease |
isolated CHD: Complex anomalies of atrioventricular connections |
risk factor |
|
71 |
outcome of ischemic placental disease |
isolated CHD: FUVH |
risk factor |
|
72 |
outcome of ischemic placental disease |
isolated CHD: CACA |
risk factor |
|
73 |
severe neonatal morbidity and mortality |
: |
risk factor |
|
74 |
perinatal mortality |
: |
risk factor |
|
75 |
major visible congenital anomalies |
: |
risk factor |
|
76 |
preterm birth<37 weeks |
: |
risk factor |
|
77 |
preterm birth<32 weeks |
: |
risk factor |
|
78 |
SGA birth |
: |
risk factor |
|
88 |
fontan status (Predictors of Recurrence After First Catheter Ablation) |
isolated CHD: ASD, VSD/AS, BAV/TOF, PS/AVC/ECD/EA/other |
risk factor |
|
89 |
Prior surgical maze (Predictors of Recurrence After First Catheter Ablation) |
isolated CHD: ASD, VSD/AS, BAV/TOF, PS/AVC/ECD/EA/other |
risk factor |
|
90 |
Failed amiodarone (Predictors of Recurrence After First Catheter Ablation) |
isolated CHD: ASD, VSD/AS, BAV/TOF, PS/AVC/ECD/EA/other |
risk factor |
|
91 |
acute procedural success (Predictors of Recurrence After First Catheter Ablation) |
isolated CHD: ASD, VSD/AS, BAV/TOF, PS/AVC/ECD/EA/other |
risk factor |
|
100 |
Pericardial effusion |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/ASD, VSD/ASD, PDA/VSD, PDA/VSD, ES/PDA, ES/VSD, CHD with PAH |
risk factor |
|
133 |
Age |
isolated CHD: VSD/ASD/TOF/TGA/PDA/AVSD/AP/AS/DORV/PA/CoA/other |
risk factor (article mentioned) |
|
134 |
weight |
isolated CHD: VSD/ASD/TOF/TGA/PDA/AVSD/AP/AS/DORV/PA/CoA/other |
risk factor (article mentioned) |
|
135 |
cross-clamp time (CCT) |
isolated CHD: VSD/ASD/TOF/TGA/PDA/AVSD/AP/AS/DORV/PA/CoA/other |
risk factor (article mentioned) |
|
136 |
cardiopulmonary bypass time (CPB) |
isolated CHD: VSD/ASD/TOF/TGA/PDA/AVSD/AP/AS/DORV/PA/CoA/other |
risk factor (article mentioned) |
|
138 |
pulmonary hypertension |
isolated CHD: VSD/ASD/TOF/TGA/PDA/AVSD/AP/AS/DORV/PA/CoA/other |
risk factor (article mentioned) |
|
139 |
impaired heart function |
isolated CHD: VSD/ASD/TOF/TGA/PDA/AVSD/AP/AS/DORV/PA/CoA/other |
risk factor (article mentioned) |
|
146 |
pre-pregnancy diabetes |
isolated CHD/non-isolated CHD: DIVM/DIVM, other |
risk factor |
|
148 |
pre-pregnancy diabetes |
isolated CHD/non-isolated CHD: DIVM/DIVM, other |
risk factor |
|
150 |
pre-pregnancy diabetes |
isolated CHD/non-isolated CHD: DIVM/DIVM, other |
risk factor |
|
152 |
maternal insulin use |
isolated CHD/non-isolated CHD: DIVM/DIVM, other |
risk factor |
|
154 |
maternal insulin use |
isolated CHD/non-isolated CHD: DIVM/DIVM, other |
risk factor |
|
156 |
paternal race (Hispanic foreign born) |
isolated CHD/non-isolated CHD: DIVM/DIVM, other |
risk factor |
|
158 |
paternal race (Hispanic U.S. born) |
isolated CHD/non-isolated CHD: DIVM/DIVM, other |
risk factor |
|
160 |
Pregnancies complicated by CHD with aortic obstruction (AO) |
isolated CHD/non-isolated CHD: DIVM/DIVM, other |
risk factor |
|
164 |
abnormal Placental Pathology |
isolated CHD/non-isolated CHD: TGA, IVS/TGA, VSD/TOF/TOF, PA/TA/TAPVC/EA/VSD, IAA/CoA, HAA/other/PA, IVS/HLHS/DORV/CoA |
risk factor |
|
165 |
moderate/severe brain leision |
isolated CHD/non-isolated CHD: TGA, IVS/TGA, VSD/TOF/TOF, PA/TA/TAPVC/EA/VSD, IAA/CoA, HAA/other/PA, IVS/HLHS/DORV/CoA |
risk factor |
|
175 |
Diastolic Blood Pressure(median[IQR] |
isolated CHD: IAVD/non-complex CHD |
risk factor (article mentioned) |
|
176 |
BMI(median[IQR] |
isolated CHD: IAVD/non-complex CHD |
risk factor (article mentioned) |
|
177 |
Obesity(%) |
isolated CHD: IAVD/non-complex CHD |
risk factor (article mentioned) |
|
178 |
Diagnosed/Treated for Hypertension(%) |
isolated CHD: IAVD/non-complex CHD |
risk factor (article mentioned) |
|
179 |
Diagnosed/Treated for Hyperlipidemia(%) |
isolated CHD: IAVD/non-complex CHD |
risk factor (article mentioned) |
|
180 |
Diagnosed/Treated for Diabets(%) |
isolated CHD: IAVD/non-complex CHD |
risk factor (article mentioned) |
|
181 |
No events of Acute Coronary Syndrome(ACS) |
isolated CHD: IAVD |
risk factor |
|
182 |
No events of Acute Coronary Syndrome(ACS) |
isolated CHD: Non-complex defects |
risk factor |
|
183 |
No. events of Ischemic Stroke |
isolated CHD: IAVD |
risk factor |
|
184 |
No. events of Ischemic Stroke |
isolated CHD: Non-complex defects |
risk factor |
|
185 |
No. events of Heart Failure |
isolated CHD: IAVD |
risk factor |
|
186 |
No. events of Heart Failure |
isolated CHD: Non-complex defects |
risk factor |
|
187 |
No. events of Atrial Fibrillation(AF) |
isolated CHD: IAVD |
risk factor |
|
188 |
No. events of Atrial Fibrillation(AF) |
isolated CHD: Non-complex defects |
risk factor |
|
189 |
number of Cardiovascular Risk factors(Low<2) |
isolated CHD: IAVD |
risk factor |
|
190 |
number of Cardiovascular Risk factors(Low<2) |
isolated CHD: Non-complex defects |
risk factor |
|
191 |
number of Cardiovascular Risk factors(Intermediate Risk 3-4) |
isolated CHD: IAVD |
risk factor |
|
192 |
number of Cardiovascular Risk factors(Intermediate Risk 3-4) |
isolated CHD: Non-complex defects |
risk factor |
|
193 |
number of Cardiovascular Risk factors(Intermediate Risk >5) |
isolated CHD: IAVD |
risk factor |
|
194 |
number of Cardiovascular Risk factors(Intermediate Risk >5) |
isolated CHD: Non-complex defects |
risk factor |
|
203 |
Suspected sepsis(incidence rate) |
NA: NA |
risk factor |
|
204 |
exposure to calcineurin inhibitors(incidence rate) |
NA: NA |
risk factor |
|
205 |
vancomycin(incidence rate) |
NA: NA |
risk factor |
|
206 |
piperacillin-tazobactam(incidence rate) |
NA: NA |
risk factor |
|
207 |
a longer duration of mechanical ventilation |
NA: NA |
risk factor |
|
208 |
intensive care unit length of stay |
NA: NA |
risk factor |
|
210 |
Overweight patients: Lesion type complex |
NA: NA |
risk factor(article mentioned) |
|
213 |
Obese patients: Lesion type complex |
isolated CHD/non-isolated CHD: A-CHD/C-CHD/NA |
risk factor(article mentioned) |
|
214 |
Obese patients: Lesion type cyanotic |
isolated CHD/non-isolated CHD: A-CHD/C-CHD/NA |
risk factor(article mentioned) |
|
215 |
cold |
NA: NA |
risk factor |
|
216 |
depression scores |
NA: NA |
risk factor (article mentioned) |
|
217 |
cold with high depression scores |
NA: NA |
risk factor |
|
218 |
cold with lower depression scores |
NA: NA |
risk factor |
|
219 |
high depression scores |
NA: NA |
risk factor |
|
220 |
cold with high depression scores(withourt fever) |
NA: NA |
risk factor |
|
224 |
female sex |
isolated CHD: CHD with PAH |
risk factor |
|
229 |
menstruation |
isolated CHD: CHD with PAH |
risk factor |
|
254 |
taking drugs during perinatal period |
NA: NA |
risk factor |
|
255 |
taking cold medicine during perinatal period |
NA: NA |
risk factor |
|
256 |
taking antibotics during perinatal period |
NA: NA |
risk factor |
|
257 |
taking salicylates during perinatal period |
NA: NA |
risk factor |
|
258 |
taking antifungal drugs during perinatal period |
NA: NA |
risk factor |
|
259 |
taking two kinds of medicines |
NA: NA |
risk factor |
|
260 |
taking cold medicine in early pregnancy |
NA: NA |
risk factor |
|
261 |
taking antibotics in early pregnancy |
NA: NA |
risk factor |
|
262 |
taking salicylates in early pregnancy |
NA: NA |
risk factor |
|
263 |
taking antifungal drugs in early pregnancy |
NA: NA |
risk factor |
|
264 |
taking other drugs in early pregnancy |
NA: NA |
risk factor |
|
265 |
Overweight |
isolated CHD/non-isolated CHD: TOF, PS, DCRV/ccTGA/ASD, VSD |
risk factor (article mentioned) |
|
266 |
obese |
isolated CHD/non-isolated CHD: TOF, PS, DCRV/ccTGA/ASD, VSD |
risk factor (article mentioned) |
|
267 |
morbidly obese |
isolated CHD/non-isolated CHD: TOF, PS, DCRV/ccTGA/ASD, VSD |
risk factor (article mentioned) |
|
268 |
Fontan |
isolated CHD/non-isolated CHD: NA |
risk factor (article mentioned) |
|
280 |
cesarean |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
282 |
fetal intolerance of labor(FIOL) |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
283 |
FIOL if underwent IOL(Induction of labor) |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
284 |
FIOL if SGA (<10th%) birthweight |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
285 |
FIOL if SGA (10–90th%) birthweight |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
286 |
Maternal hospital transfer |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
287 |
Delivery at academic center |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
289 |
SGA birthweight (<10th%) |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
290 |
Low birthweight (<2,500 g) |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
291 |
NICU admission |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
292 |
Neonate transferred |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
293 |
Apgar 5-min score (<7) |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
294 |
Apgar 5-min score |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
295 |
Neonatal death |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
296 |
Infant death |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
297 |
Assisted ventilation |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
298 |
Surfactant administration |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
299 |
Antibiotics for suspected sepsis |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
303 |
Preterm birth <37 week |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
306 |
fetal intolerance of labor |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
328 |
PDW value |
isolated CHD: PA/TGA/DORV/SV/TOF/TA |
risk factor |
|
329 |
increase of MPV |
isolated CHD: PA/TGA/DORV/SV/TOF/TA |
risk factor |
|
330 |
increase of PDW |
isolated CHD: PA/TGA/DORV/SV/TOF/TA |
risk factor (article mentioned) |
|
333 |
death |
isolated CHD/non-isolated CHD: VSD/VSD, PDA/CoA/CAVC/DORV |
risk factor (article mentioned) |
|
334 |
hospitalization |
isolated CHD/non-isolated CHD: VSD/VSD, PDA/CoA/CAVC/DORV |
risk factor (article mentioned) |
|
335 |
new onset of arrhytnmias |
isolated CHD/non-isolated CHD: VSD/VSD, PDA/CoA/CAVC/DORV |
risk factor (article mentioned) |
|
336 |
surgical |
isolated CHD/non-isolated CHD: VSD/VSD, PDA/CoA/CAVC/DORV |
risk factor (article mentioned) |
|
356 |
premature birth-direct effect on executive dysfunction |
isolated CHD/non-isolated CHD: D-TGA, IVS/D-TGA, VSD/TOF/TOF, PS/TA/VSD/TA, IAA/VSD, CoA/CoA, AH/PS, IVS/SV/HLHS/SV, AO |
risk factor |
|
357 |
male sex-direct effect on executive dysfunction |
isolated CHD/non-isolated CHD: D-TGA, IVS/D-TGA, VSD/TOF/TOF, PS/TA/VSD/TA, IAA/VSD, CoA/CoA, AH/PS, IVS/SV/HLHS/SV, AO |
risk factor |
|
365 |
Low physical HRQoL-Female sex |
isolated CHD/non-isolated CHD: BAV/RVSD/MVD/PVS/AVD/ASD/VSD/SVD/PDA/CoA/EA/PS/AVSD/SVAS/HCM/TOF/DORV/RVD/Shone's Complex/PA/ccTGA/TGA/ES/C-CHD/other |
risk factor |
|
366 |
Low mental HRQoL-Female sex |
isolated CHD/non-isolated CHD: BAV/RVSD/MVD/PVS/AVD/ASD/VSD/SVD/PDA/CoA/EA/PS/AVSD/SVAS/HCM/TOF/DORV/RVD/Shone's Complex/PA/ccTGA/TGA/ES/C-CHD/other |
risk factor |
|
367 |
Impaired poor psychological adjustment-Female sex |
isolated CHD/non-isolated CHD: BAV/RVSD/MVD/PVS/AVD/ASD/VSD/SVD/PDA/CoA/EA/PS/AVSD/SVAS/HCM/TOF/DORV/RVD/Shone's Complex/PA/ccTGA/TGA/ES/C-CHD/other |
risk factor |
|
372 |
Impaired poor psychological adjustment- number of significant life events |
isolated CHD/non-isolated CHD: BAV/RVSD/MVD/PVS/AVD/ASD/VSD/SVD/PDA/CoA/EA/PS/AVSD/SVAS/HCM/TOF/DORV/RVD/Shone's Complex/PA/ccTGA/TGA/ES/C-CHD/other |
risk factor |
|
378 |
total number of central venous catheter (CVC) |
isolated CHD: HRHS/HLHS/other |
risk factor |
|
400 |
congenital diagnosis |
isolated CHD: AS/AC/TOF/EA/AVSD/ccTGA/CHD with PAH/FUVH |
risk factor |
|
401 |
NYHA class |
isolated CHD: AS/AC/TOF/EA/AVSD/ccTGA/CHD with PAH/FUVH |
risk factor |
|
402 |
cardiac medication |
isolated CHD: AS/AC/TOF/EA/AVSD/ccTGA/CHD with PAH/FUVH |
risk factor |
|
403 |
re-intervention |
isolated CHD: AS/AC/TOF/EA/AVSD/ccTGA/CHD with PAH/FUVH |
risk factor |
|
405 |
NT-proBNP |
isolated CHD: AS/AC/TOF/EA/AVSD/ccTGA/CHD with PAH/FUVH |
risk factor |
|
406 |
Abnormal brain activity |
NA: BVP/BVP-AAO/SV |
risk factor |
|
419 |
the mutant allete T of 5,10 methylenetetrahydrofolate reductase (MTHFR) C677T T |
isolated CHD: ASD/VSD/PDA/TOF/PVS |
risk factor |
|
420 |
the mutant allete CT of 5,10 methylenetetrahydrofolate reductase (MTHFR) C677T CT |
isolated CHD: ASD/VSD/PDA/TOF/PVS |
risk factor |
|
421 |
the mutant allete TT of 5,10 methylenetetrahydrofolate reductase (MTHFR) C677T TT |
isolated CHD: ASD/VSD/PDA/TOF/PVS |
risk factor |
|
424 |
MTHFR(C677T)CT/(A1298C)AA |
isolated CHD: ASD/VSD/PDA/TOF/PVS |
risk factor |
|
425 |
MTHFR(C677T)TT/(A1298C)AA |
isolated CHD: ASD/VSD/PDA/TOF/PVS |
risk factor |
|
430 |
neurocognitive deficits |
NA: NA |
risk factor (article mentioned) |
|
447 |
intra-atrial re- entrant tachycardia(IART) different than isolated cavotricuspid isthmus(CTI) first procedure |
isolated CHD: GVT/TOF/ASD/SV/VSD/AVSD/EA/other |
risk factor |
|
448 |
intra-atrial re- entrant tachycardia(IART) different than isolated cavotricuspid isthmus(CTI) in all follow-up |
isolated CHD: GVT/TOF/ASD/SV/VSD/AVSD/EA/other |
risk factor |
|
449 |
PR interval >200 ms |
isolated CHD: GVT/TOF/ASD/SV/VSD/AVSD/EA/other |
risk factor |
|
450 |
Atrial fibrillation(AF) induction |
isolated CHD: GVT/TOF/ASD/SV/VSD/AVSD/EA/other |
risk factor |
|
451 |
Previous atrial fibrillation |
isolated CHD: GVT/TOF/ASD/SV/VSD/AVSD/EA/other |
risk factor |
|
453 |
vasoactive-inotropic score (VIS) |
isolated CHD: TOF/AVC/CAT/HLHS/CoA, IAA/MR, AOR/PA/TAPVC/TGA/VSD/ASD/other |
risk factor |
|
468 |
positive family history |
NA: NA |
risk factor (article mentioned) |
|
469 |
consanguinity |
NA: NA |
risk factor (article mentioned) |
|
470 |
maternal diabetes |
NA: NA |
risk factor (article mentioned) |
|
471 |
antiepileptics use by the mother |
NA: NA |
risk factor (article mentioned) |
|
473 |
no folic acid used by the mother |
NA: NA |
risk factor (article mentioned) |
|
481 |
previous atrial fibrillation |
isolated CHD/non-isolated CHD: TOF/ASD/SV/SPF/other/VSD/ASD/EA/CHD with IART |
risk factor |
|
482 |
transposition of great arteries(TGA) |
isolated CHD/non-isolated CHD: TOF/ASD/SV/SPF/other/VSD/ASD/EA/CHD with IART |
risk factor |
|
483 |
systemic ventricle dilation |
isolated CHD/non-isolated CHD: TOF/ASD/SV/SPF/other/VSD/ASD/EA/CHD with IART |
risk factor |
|
484 |
Moderate-to-severe dilation of systemic ventricle |
isolated CHD/non-isolated CHD: TOF/ASD/SV/SPF/other/VSD/ASD/EA/CHD with IART |
risk factor |
|
486 |
Grade III degree of cardiac disease complexity |
isolated CHD/non-isolated CHD: TOF/ASD/SV/SPF/other/VSD/ASD/EA/CHD with IART |
risk factor |
|
487 |
atrial fibrillation induction |
isolated CHD/non-isolated CHD: TOF/ASD/SV/SPF/other/VSD/ASD/EA/CHD with IART |
risk factor |
|
490 |
RF success of IART different than isolated CTI dependent IART |
isolated CHD/non-isolated CHD: TOF/ASD/SV/SPF/other/VSD/ASD/EA/CHD with IART |
risk factor |
|
491 |
occupational statuses of the mothers (Blue collar) |
isolated CHD/non-isolated CHD: VSD/ASD/TOF/DORV/PDA/NA |
risk factor |
|
492 |
mothers' drug exposure during gestation |
isolated CHD/non-isolated CHD: VSD/ASD/TOF/DORV/PDA/NA |
risk factor |
|
493 |
frequencies of MTHFR gene 677 TT genotype in the mothers |
isolated CHD/non-isolated CHD: VSD/ASD/TOF/DORV/PDA/NA |
risk factor |
|
494 |
frequencies of MTHFR gene 677 TT genotype in CHD children |
isolated CHD: ASD |
risk factor |
|
495 |
frequencies of MTHFR gene 677 TT genotype in the mothers |
isolated CHD: TOF |
risk factor |
|
496 |
frequencies of MTHFR gene 677 TT genotype in the mothers |
isolated CHD: DORV |
risk factor |
|
497 |
frequencies of MTHFR gene 677 TT genotype in the mothers |
isolated CHD: PDA |
risk factor |
|
498 |
Genotypes of SNP rs2243890 A>G in RCAN1.4 promoter region |
NA: NA |
risk factor |
|
508 |
teacher reported attention problems |
isolated CHD/non-isolated CHD: SV/HLHS/Taussig–Bing anomaly/IAA, HAA/CoA, HAA |
risk factor |
|
513 |
Median RDW |
NA: NA |
risk factor (article mentioned) |
|
539 |
Percent of Dementia Events without extracardiac defects |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/CoA/TOF/TGA/TA/other |
risk factor |
|
540 |
Percent of Dementia Events without acquired cardiovascular disease or diabetes mellitus |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/CoA/TOF/TGA/TA/other |
risk factor |
|
541 |
New York Heart Association functional class (patients in class 3 and 4) |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/PS/AOS/Bc/CoA/D-TGA/ccTGA/TOF/EA/other |
risk factor |
|
542 |
N-terminal proB-type natriuretic peptide levels >125 pg/mL(NT pro-BNP) |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/PS/AOS/Bc/CoA/D-TGA/ccTGA/TOF/EA/other |
risk factor |
|
546 |
altitude |
isolated CHD: PDA/ASD/VSD |
risk factor (article mentioned) |
|
551 |
CIAS(Childhood Illness Attitude Scales) |
NA: NA |
risk factor (article mentioned) |
|
552 |
CASI (Children’s Anxiety Sensitivity Index)score |
NA: NA |
risk factor (article mentioned) |
|
553 |
SCAS(Spence Children’s Anxiety Scale) total score |
NA: NA |
risk factor (article mentioned) |
|
569 |
major complication during interventional procedures |
isolated CHD/non-isolated CHD: MID, superior inferior ventricles, PA, VSD, ASD/AVSD, CoA, PDA/TAPVC/PDA, PFO, PDA/TGA/HLHS/HLHS, PDA, CoA/other |
risk factor |
|
575 |
interventional procedures |
isolated CHD/non-isolated CHD: MID, superior inferior ventricles, PA, VSD, ASD/AVSD, CoA, PDA/TAPVC/PDA, PFO, PDA/TGA/HLHS/HLHS, PDA, CoA/other |
risk factor |
|
584 |
CSF/ICV(intracranial volume) |
isolated CHD: SV |
risk factor (article mentioned) |
|
594 |
AhR p.Arg554Lys-Additive(Arg/Arg vs.Arg/Lys vs.Lys/Lys) |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
risk factor |
|
595 |
AhR p.Arg554Lys-Dominant(Lys/Lys and Arg/Lys vs.Arg/Arg) |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
risk factor |
|
597 |
maternal exposure combined with Arg/Arg |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
risk factor |
|
598 |
Lys/Lys and Arg/Lys without maternal exposure |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
risk factor |
|
599 |
Lys/Lys and Arg/Lys combined with maternal exposure |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
risk factor |
|
602 |
Lys/Lys and Arg/Lys without maternal somking |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
risk factor |
|
603 |
Lys/Lys and Arg/Lys combined with maternal somking |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
risk factor |
|
605 |
paternal exposure combined with Arg/Arg |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
risk factor |
|
606 |
Lys/Lys and Arg/Lys without paternal exposure |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
risk factor |
|
607 |
Lys/Lys and Arg/Lys combined with paternal exposure |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
risk factor |
|
609 |
paternal smoking combined with Arg/Arg |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
risk factor |
|
610 |
Lys/Lys and Arg/Lys without paternal somking |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
risk factor |
|
611 |
Lys/Lys and Arg/Lys combined with paternal somking |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
risk factor |
|
653 |
age at surgery <30 days |
isolated CHD/non-isolated CHD: HLHS/DORV/TOF, PA/D-TGA/D-TGA, VSD/TGA/VSD, IAA/TA/PA/DORV, VSD/other |
risk factor |
|
654 |
use of milrinone |
isolated CHD/non-isolated CHD: HLHS/DORV/TOF, PA/D-TGA/D-TGA, VSD/TGA/VSD, IAA/TA/PA/DORV, VSD/other |
risk factor |
|
655 |
NYHA class II |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/ECD/TOF/EA/DORV/VSD, ES/PDA, ES/ASD, VSD, PDA, ES/ASD, ES |
risk factor |
|
657 |
Eisenmenger syndrome(ES) |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/ECD/TOF/EA/DORV/VSD, ES/PDA, ES/ASD, VSD, PDA, ES/ASD, ES |
risk factor |
|
659 |
respiratory failure |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/ECD/TOF/EA/DORV/VSD, ES/PDA, ES/ASD, VSD, PDA, ES/ASD, ES |
risk factor (article mentioned) |
|
668 |
presence of prosthetic material with recurrent IE |
isolated CHD/non-isolated CHD: D-TGA/D-TGA, VSD, PS/D-TGA, VSD, PA/AVSD/VSD, TVR/VSD, BAV/mechanical AVR for BAV/BAV |
risk factor |
|
669 |
cerebral emboli |
isolated CHD/non-isolated CHD: D-TGA/D-TGA, VSD, PS/D-TGA, VSD, PA/AVSD/VSD, TVR/VSD, BAV/mechanical AVR for BAV/BAV |
risk factor |
|
670 |
acute renal failure |
isolated CHD/non-isolated CHD: D-TGA/D-TGA, VSD, PS/D-TGA, VSD, PA/AVSD/VSD, TVR/VSD, BAV/mechanical AVR for BAV/BAV |
risk factor |
|
671 |
death rate |
isolated CHD/non-isolated CHD: D-TGA/D-TGA, VSD, PS/D-TGA, VSD, PA/AVSD/VSD, TVR/VSD, BAV/mechanical AVR for BAV/BAV |
risk factor |
|
672 |
risk factor correlated with primary outcome: 2V-RV |
isolated CHD: C-CHD/1V/2V-RV/2V-LV |
risk factor |
|
673 |
risk factor correlated with primary outcome:: NYHA |
isolated CHD: C-CHD/1V/2V-RV/2V-LV |
risk factor |
|
674 |
risk event rate[B-type natriuretic peptide(BNP) level] |
isolated CHD: C-CHD/1V/2V-RV/2V-LV |
risk factor |
|
675 |
risk event rate[Sodium level] |
isolated CHD: C-CHD/1V/2V-RV/2V-LV |
risk factor |
|
687 |
Lactic acid post-operation |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
688 |
von Willebrand factor(vWF) activity pre-operation |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
689 |
vWF concentration pre-operation |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
692 |
single ventricle(SV) |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
720 |
Cp(pulmonary artery compliance) |
isolated CHD: CHD with PAH/EA |
risk factor |
|
721 |
correlation with pulmonary artery compliance(Cp) and Heart rate |
isolated CHD: CHD with PAH/EA |
risk factor |
|
722 |
correlation with Cp and 6-MWD |
isolated CHD: CHD with PAH/EA |
risk factor |
|
723 |
correlation with Cp and pulmonary blood flow |
isolated CHD: CHD with PAH/EA |
risk factor |
|
724 |
correlation with Cp and PAR(pulmonary artery resistance) |
isolated CHD: CHD with PAH/EA |
risk factor |
|
726 |
Incedence of Death |
isolated CHD: ASD/TOF/VSD/UVH/TGA/BAV |
risk factor |
|
727 |
Incedence of heart failure(HF) |
isolated CHD: ASD/TOF/VSD/UVH/TGA/BAV |
risk factor |
|
728 |
new-onset stroke |
isolated CHD: ASD/TOF/VSD/UVH/TGA/BAV |
risk factor |
|
729 |
stroke incidence of different defect |
isolated CHD: ASD/TOF/VSD/UVH/TGA/BAV |
risk factor |
|
730 |
stroke incidence of different defect |
isolated CHD: ASD/TOF/VSD/UVH/TGA/BAV |
risk factor |
|
731 |
stroke incidence of different age |
isolated CHD: ASD/TOF/VSD/UVH/TGA/BAV |
risk factor |
|
740 |
previous intracardiac repair |
isolated CHD: LVOTO/ASD/VSD/CoA/TOF/D-TGA/DORV/AVSD/ccTGA/PA/SV/ES/EA |
risk factor |
|
741 |
pulmonary regurgitation |
isolated CHD: LVOTO/ASD/VSD/CoA/TOF/D-TGA/DORV/AVSD/ccTGA/PA/SV/ES/EA |
risk factor |
|
742 |
pulmonary AV valve regurgitation |
isolated CHD: LVOTO/ASD/VSD/CoA/TOF/D-TGA/DORV/AVSD/ccTGA/PA/SV/ES/EA |
risk factor |
|
743 |
pulmonary ventricular dysfunction |
isolated CHD: LVOTO/ASD/VSD/CoA/TOF/D-TGA/DORV/AVSD/ccTGA/PA/SV/ES/EA |
risk factor |
|
744 |
single ventricle physiology |
isolated CHD: LVOTO/ASD/VSD/CoA/TOF/D-TGA/DORV/AVSD/ccTGA/PA/SV/ES/EA |
risk factor |
|
745 |
systemic right ventricle |
isolated CHD: LVOTO/ASD/VSD/CoA/TOF/D-TGA/DORV/AVSD/ccTGA/PA/SV/ES/EA |
risk factor |
|
746 |
severe pulmonary hypertension |
isolated CHD: LVOTO/ASD/VSD/CoA/TOF/D-TGA/DORV/AVSD/ccTGA/PA/SV/ES/EA |
risk factor |
|
747 |
univentricular physiology |
isolated CHD: LVOTO/ASD/VSD/CoA/TOF/D-TGA/DORV/AVSD/ccTGA/PA/SV/ES/EA |
risk factor |
|
748 |
Fontan procedure |
isolated CHD: LVOTO/ASD/VSD/CoA/TOF/D-TGA/DORV/AVSD/ccTGA/PA/SV/ES/EA |
risk factor |
|
749 |
complex CHD |
isolated CHD: LVOTO/ASD/VSD/CoA/TOF/D-TGA/DORV/AVSD/ccTGA/PA/SV/ES/EA |
risk factor |
|
758 |
Low folate≤11.33nmol/L |
NA: NA |
risk factor (article mentioned) |
|
759 |
High homocysteine Adult >15 μmol/l；child >10 μmol/l |
NA: NA |
risk factor (article mentioned) |
|
760 |
folate(nmol/L) |
NA: NA |
risk factor (article mentioned) |
|
761 |
homocysteine (μmol/l) |
NA: NA |
risk factor (article mentioned) |
|
762 |
MTHFR C677T polymorphic(TT+CT) |
NA: NA |
risk factor (article mentioned) |
|
763 |
MTRR A66G polymorphic(AG+GG) |
NA: NA |
risk factor |
|
764 |
MTHFR C677T polymorphic(TT+CT) and MTRR A66G polymorphic(AG+GG) |
NA: NA |
risk factor |
|
765 |
MTHFR C677T polymorphic(TT+CT) and MTRR A66G polymorphic(AG+GG) |
NA: NA |
risk factor |
|
766 |
low folate levels and MTR A2756G |
NA: NA |
risk factor |
|
767 |
low folate levels and MTHFR A1298C |
NA: NA |
risk factor |
|
768 |
low folate levels and MTRR A66G |
NA: NA |
risk factor |
|
769 |
high homocysteine and MTHFR C677T |
NA: NA |
risk factor |
|
770 |
high homocysteine and MTR A2756G |
NA: NA |
risk factor |
|
794 |
thoracotomies(n) |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
796 |
oxygen saturation at rest(%) |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
801 |
independent predictors of a restrictive lung pattern(thoracotomies) |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
802 |
independent predictors of a restrictive lung pattern(Cyanosis) |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
803 |
independent predictors of a restrictive lung pattern(Pacer) |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
804 |
independent predictors of a restrictive lung pattern(Complexity) |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
805 |
independent predictors of a restrictive lung pattern(Beta-blocker) |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
809 |
independent predictors of an impaired exercise capacity(Thoracotomies) |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
811 |
independent predictors of an impaired exercise capacity (cyanosis) |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
812 |
independent predictors of an impaired exercise capacity (complexity) |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
813 |
independent predictors of an impaired exercise capacity(beta-blocker) |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
867 |
predischarge SAVV regurgitation grade |
isolated CHD/non-isolated CHD: AVSD/ccTGA/MS, MR |
risk factor |
|
892 |
Cumulative incidence of CKD--5 years post-CS |
NA: NA |
risk factor (article mentioned) |
|
893 |
Cox regression--Overall CS-AKI and CKD |
NA: NA |
risk factor |
|
894 |
Cox regression--CS-AKI and CKD >1 yr post-CS |
NA: NA |
risk factor |
|
903 |
incidence rate oflow cardiac output syndrome n(%) |
isolated CHD/non-isolated CHD: VSD/ASD/VSD, ASD/TOF, DORV/TGA/TAPVC/PA/other |
risk factor(article mentioned) |
|
909 |
levels of cumulative fluid overload 2 days after surgery (x±s, %) |
isolated CHD/non-isolated CHD: VSD/ASD/VSD, ASD/TOF, DORV/TGA/TAPVC/PA/other |
risk factor(article mentioned) |
|
965 |
GIT symptoms--Age at onset of symptoms (<6 month) (percent) |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
risk factor(article mentioned) |
|
969 |
GIT symptoms--Age at onset of symptoms (<6 month) (percent) |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
risk factor(article mentioned) |
|
973 |
GIT symptoms--Age at onset of symptoms (<6 month) (percent) |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
risk factor(article mentioned) |
|
1017 |
Impaired mental HrQoL--Pacemaker |
isolated CHD: TOF/PS/AS/CoA/TGA/EA/ASD/VSD/AVSD |
risk factor |
|
1018 |
Impaired physical HrQoL--Pacemaker |
isolated CHD: TOF/PS/AS/CoA/TGA/EA/ASD/VSD/AVSD |
risk factor |
|
1019 |
Impaired exercise capacity--Pacemaker |
isolated CHD: TOF/PS/AS/CoA/TGA/EA/ASD/VSD/AVSD |
risk factor |
|
1020 |
Impaired physical HrQoL--Beta-blocker intake |
isolated CHD: TOF/PS/AS/CoA/TGA/EA/ASD/VSD/AVSD |
risk factor |
|
1021 |
Impaired exercise capacity--Beta-blocker intake |
isolated CHD: TOF/PS/AS/CoA/TGA/EA/ASD/VSD/AVSD |
risk factor |
|
1022 |
Impaired exercise capacity--Severity of heart defect |
isolated CHD: TOF/PS/AS/CoA/TGA/EA/ASD/VSD/AVSD |
risk factor |
|
1023 |
Impaired exercise capacity--Severity of heart defect |
isolated CHD: TOF/PS/AS/CoA/TGA/EA/ASD/VSD/AVSD |
risk factor |
|
1040 |
Predictors of procedural failure--Fontan physiology |
isolated CHD/non-isolated CHD: ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
risk factor |
|
1041 |
Predictors of procedural failure--Non-Fontan single-ventricle physiology |
isolated CHD/non-isolated CHD: ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
risk factor(article mentioned) |
|
1042 |
Predictors of procedural failure--Atrial fibrillation |
isolated CHD/non-isolated CHD: ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
risk factor(univariable model) |
|
1043 |
Predictors of procedural failure--Spontaneous echocardiographic contrast |
isolated CHD/non-isolated CHD: ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
risk factor |
|
1045 |
Predictors of arrhythmia recurrence--Fontan physiology |
isolated CHD/non-isolated CHD: ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
risk factor |
|
1046 |
Predictors of arrhythmia recurrence--Prior Mustard procedure |
isolated CHD/non-isolated CHD: ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
risk factor(univariable model) |
|
1047 |
Predictors of arrhythmia recurrence--Atrial fibrillation |
isolated CHD/non-isolated CHD: ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
risk factor |
|
1048 |
Predictors of arrhythmia recurrence--Moderate-severe systemic ventricular dysfunction |
isolated CHD/non-isolated CHD: ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
risk factor(univariable model) |
|
1102 |
cTn-I 2 h PO > 14 ng/mL (cardiac troponin I) |
isolated CHD/non-isolated CHD: TOF/AVC/CoA/IAA/PA/TGA/VSD, ASD/CAT/HLHS/TAPVC/AR/other |
risk factor |
|
1105 |
MR-proADM 24 h PO > 1.5 nmol/L |
isolated CHD/non-isolated CHD: TOF/AVC/CoA/IAA/PA/TGA/VSD, ASD/CAT/HLHS/TAPVC/AR/other |
risk factor |
|
1168 |
Inotrope using--≥72 hr |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
risk factor |
|
1169 |
Age--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
risk factor |
|
1171 |
PH--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
risk factor |
|
1174 |
Heart failure--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
risk factor |
|
1176 |
Inotrope using--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD, PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA, PAH/other |
risk factor |
|
1221 |
Aortic cross clamp time (ACC time)(min) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
risk factor |
|
1222 |
Cardiopulmonary bypass time (min) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
risk factor |
|
1223 |
Increasing rate of Lac |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
risk factor |
|
1224 |
Procalcitonin |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
risk factor |
|
1225 |
Intraop. blood loss |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
risk factor |
|
1226 |
Age ⩾35 years |
isolated CHD: TOF/EA/PAPVC/L-TGA/AS/ASD/Shone's Complex/CACA/D-TGA/DCRV/PA, IVS/AVC/SAM/AR/ARA/AC/MR/PVS/VSD/DILV/DORV/HLHS/TR/TAS |
risk factor |
|
1227 |
preoperative left ventricular dysfunction |
isolated CHD: TOF/EA/PAPVC/L-TGA/AS/ASD/Shone's Complex/CACA/D-TGA/DCRV/PA, IVS/AVC/SAM/AR/ARA/AC/MR/PVS/VSD/DILV/DORV/HLHS/TR/TAS |
risk factor |
|
1228 |
history of arrhythmia |
isolated CHD: TOF/EA/PAPVC/L-TGA/AS/ASD/Shone's Complex/CACA/D-TGA/DCRV/PA, IVS/AVC/SAM/AR/ARA/AC/MR/PVS/VSD/DILV/DORV/HLHS/TR/TAS |
risk factor |
|
1229 |
longer bypass time |
isolated CHD: TOF/EA/PAPVC/L-TGA/AS/ASD/Shone's Complex/CACA/D-TGA/DCRV/PA, IVS/AVC/SAM/AR/ARA/AC/MR/PVS/VSD/DILV/DORV/HLHS/TR/TAS |
risk factor |
|
1230 |
higher Risk Adjustment for Congenital Heart Surgery-1(RACHS-1) category |
isolated CHD: TOF/EA/PAPVC/L-TGA/AS/ASD/Shone's Complex/CACA/D-TGA/DCRV/PA, IVS/AVC/SAM/AR/ARA/AC/MR/PVS/VSD/DILV/DORV/HLHS/TR/TAS |
risk factor |
|
1231 |
perioperative vancomycin use |
isolated CHD: TOF/EA/PAPVC/L-TGA/AS/ASD/Shone's Complex/CACA/D-TGA/DCRV/PA, IVS/AVC/SAM/AR/ARA/AC/MR/PVS/VSD/DILV/DORV/HLHS/TR/TAS |
risk factor |
|
1234 |
prevalence of parent reported executive dysfunction |
isolated CHD/non-isolated CHD: D-TGA, IVS/D-TGA, VSD/TOF/TOF, PA/TA/VSD/AVC/TA, IAA/VSD, CoA/CoA/AH/SV/PA, IVS/SV/HLHS/other |
risk factor |
|
1235 |
working memory dysfunction |
isolated CHD/non-isolated CHD: D-TGA, IVS/D-TGA, VSD/TOF/TOF, PA/TA/VSD/AVC/TA, IAA/VSD, CoA/CoA/AH/SV/PA, IVS/SV/HLHS/other |
risk factor |
|
1236 |
behavior regulation index(shift) |
isolated CHD/non-isolated CHD: D-TGA, IVS/D-TGA, VSD/TOF/TOF, PA/TA/VSD/AVC/TA, IAA/VSD, CoA/CoA/AH/SV/PA, IVS/SV/HLHS/other |
risk factor |
|
1237 |
Male Gender |
isolated CHD/non-isolated CHD: D-TGA, IVS/D-TGA, VSD/TOF/TOF, PA/TA/VSD/AVC/TA, IAA/VSD, CoA/CoA/AH/SV/PA, IVS/SV/HLHS/other |
risk factor |
|
1238 |
premature birth (≤37 weeks) |
isolated CHD/non-isolated CHD: D-TGA, IVS/D-TGA, VSD/TOF/TOF, PA/TA/VSD/AVC/TA, IAA/VSD, CoA/CoA/AH/SV/PA, IVS/SV/HLHS/other |
risk factor |
|
1239 |
CHD with aortic obstruction (AO) |
isolated CHD/non-isolated CHD: D-TGA, IVS/D-TGA, VSD/TOF/TOF, PA/TA/VSD/AVC/TA, IAA/VSD, CoA/CoA/AH/SV/PA, IVS/SV/HLHS/other |
risk factor |
|
1254 |
Infant mortality rate for CHD in different ethnic |
NA: LSOOL/CTDs/RSOOL/SD/AVSD/Lesions of veins/Lesions of arteries |
risk factor |
|
1255 |
Mortality of CHD in the postneonatal (28-364 day) period in different ethnic |
NA: LSOOL/CTDs/RSOOL/SD/AVSD/Lesions of veins/Lesions of arteries |
risk factor |
|
1256 |
Mortality of CHD in the neonatal (<28day) period |
NA: LSOOL/CTDs/RSOOL/SD/AVSD/Lesions of veins/Lesions of arteries |
risk factor |
|
1257 |
African American–white disparity in postneonatal mortality rate due to CHD |
NA: LSOOL/CTDs/RSOOL/SD/AVSD/Lesions of veins/Lesions of arteries |
risk factor |
|
1260 |
preoperative digoxin exposure |
isolated CHD/non-isolated CHD: TOF/VSD/HLHS/ASD/CAVC |
risk factor |
|
1262 |
VSD closure |
isolated CHD/non-isolated CHD: TOF/VSD/HLHS/ASD/CAVC |
risk factor |
|
1263 |
a common polymorphism in the gene encoding Connexin-40(GJA5-rs10465855-TT-genotype) |
isolated CHD/non-isolated CHD: TOF/VSD/HLHS/ASD/CAVC |
risk factor |
|
1264 |
Junctional acceleration (JA) |
isolated CHD/non-isolated CHD: TOF/VSD/HLHS/ASD/CAVC |
risk factor |
|
1265 |
intermittent conduction noted during complete AV block |
isolated CHD/non-isolated CHD: TOF/VSD/HLHS/ASD/CAVC |
risk factor |
|
1271 |
Percent of fQRS (fragment QRS) |
isolated CHD: AV/ASD/ccTGA/CoA/EA/PA/PDA/PS/TGA/TOF/UVH/VSD |
risk factor |
|
1272 |
moderate/severe non-systemic ventricular dysfunction |
isolated CHD: AV/ASD/ccTGA/CoA/EA/PA/PDA/PS/TGA/TOF/UVH/VSD |
risk factor |
|
1273 |
percent of prolonged QRS complexes (QRS ≥120ms) |
isolated CHD: AV/ASD/ccTGA/CoA/EA/PA/PDA/PS/TGA/TOF/UVH/VSD |
risk factor |
|
1274 |
Percent of surgical procedures (≥3) |
isolated CHD: AV/ASD/ccTGA/CoA/EA/PA/PDA/PS/TGA/TOF/UVH/VSD |
risk factor |
|
1275 |
reintervention age |
isolated CHD: TOF/CAVC/PS/PA |
risk factor |
|
1276 |
reintervention time of valve type |
isolated CHD: TOF/CAVC/PS/PA |
risk factor |
|
1277 |
reintervention time of valve type |
isolated CHD: TOF/CAVC/PS/PA |
risk factor |
|
1278 |
number of offspring with CHD(mother with diabetes mellitus, type 1) |
isolated CHD/non-isolated CHD: ASD/PDA/VSD/PS/CoA/ECD/AS/EA/other/TOF/TGA/DORV/TAPVR/Common ventricle/HLHS/Common truncus/TA/ccTGA |
risk factor |
|
1279 |
number of offspring with CHD(mother with diabetes mellitus, type 2) |
isolated CHD/non-isolated CHD: ASD/PDA/VSD/PS/CoA/ECD/AS/EA/other/TOF/TGA/DORV/TAPVR/Common ventricle/HLHS/Common truncus/TA/ccTGA |
risk factor |
|
1280 |
number of offspring with CHD(mothers with hypertension) |
isolated CHD/non-isolated CHD: ASD/PDA/VSD/PS/CoA/ECD/AS/EA/other/TOF/TGA/DORV/TAPVR/Common ventricle/HLHS/Common truncus/TA/ccTGA |
risk factor |
|
1281 |
number of offspring with CHD(mothers with congenital heart defects) |
isolated CHD/non-isolated CHD: ASD/PDA/VSD/PS/CoA/ECD/AS/EA/other/TOF/TGA/DORV/TAPVR/Common ventricle/HLHS/Common truncus/TA/ccTGA |
risk factor |
|
1282 |
number of offspring with CHD(mothers with anemia) |
isolated CHD/non-isolated CHD: ASD/PDA/VSD/PS/CoA/ECD/AS/EA/other/TOF/TGA/DORV/TAPVR/Common ventricle/HLHS/Common truncus/TA/ccTGA |
risk factor |
|
1283 |
number of offspring with CHD(mothers with connective tissue disorders) |
isolated CHD/non-isolated CHD: ASD/PDA/VSD/PS/CoA/ECD/AS/EA/other/TOF/TGA/DORV/TAPVR/Common ventricle/HLHS/Common truncus/TA/ccTGA |
risk factor |
|
1284 |
number of offspring with CHD(mothers with epilepsy) |
isolated CHD/non-isolated CHD: ASD/PDA/VSD/PS/CoA/ECD/AS/EA/other/TOF/TGA/DORV/TAPVR/Common ventricle/HLHS/Common truncus/TA/ccTGA |
risk factor |
|
1285 |
number of offspring with CHD(mothers with mood disorders) |
isolated CHD/non-isolated CHD: ASD/PDA/VSD/PS/CoA/ECD/AS/EA/other/TOF/TGA/DORV/TAPVR/Common ventricle/HLHS/Common truncus/TA/ccTGA |
risk factor |
|
1286 |
prevalence of severe CHD(mothers with diabetes mellitus type 2) |
isolated CHD/non-isolated CHD: ASD/PDA/VSD/PS/CoA/ECD/AS/EA/other/TOF/TGA/DORV/TAPVR/Common ventricle/HLHS/Common truncus/TA/ccTGA |
risk factor |
|
1287 |
prevalence of severe CHD(mothers with congenital heart defects) |
isolated CHD/non-isolated CHD: ASD/PDA/VSD/PS/CoA/ECD/AS/EA/other/TOF/TGA/DORV/TAPVR/Common ventricle/HLHS/Common truncus/TA/ccTGA |
risk factor |
|
1288 |
Wechsler Intelligence Scales:Verbal Comprehension of early-term birth |
isolated CHD: SV |
risk factor(article mentioned) |
|
1289 |
GEC T score(Brief parent-report) of early-term birth |
isolated CHD: SV |
risk factor(article mentioned) |
|
1296 |
Parent corrers' scaning ADHD Index T score |
isolated CHD: SV |
risk factor |
|
1308 |
longer hospital stay |
isolated CHD/non-isolated CHD: SV/TOF/TGA/PVS/MVA/AVA/other |
risk factor |
|
1313 |
patients with QRS ≥180 ms |
isolated CHD/non-isolated CHD: TOF/PA, VSD/PS, DORV/PS, VSD/PS, DORV, VSD/DORV, VSD |
risk factor (article mentioned) |
|
1322 |
absolute QRS duration |
isolated CHD/non-isolated CHD: TOF/PA, VSD/PS, DORV/PS, VSD/PS, DORV, VSD/DORV, VSD |
risk factor (article mentioned) |
|
1330 |
QRS duration >=5ms/year |
isolated CHD: ES/TGA/TOF/LSOD/ASD/VSD/AVSD/Cyanotic non-ES/EA/other |
risk factor |
|
1331 |
Change from any baseline systemic ventricular function to severe ventricular dysfunction over time |
isolated CHD: ES/TGA/TOF/LSOD/ASD/VSD/AVSD/Cyanotic non-ES/EA/other |
risk factor |
|
1332 |
Impairment of SVF (systemic ventricular function) p/y |
isolated CHD: ES/TGA/TOF/LSOD/ASD/VSD/AVSD/Cyanotic non-ES/EA/other |
risk factor |
|
1333 |
Impairment of SVF ≥1 point p/y |
isolated CHD: ES/TGA/TOF/LSOD/ASD/VSD/AVSD/Cyanotic non-ES/EA/other |
risk factor |
|
1334 |
Impairment of SPVF (subpulmonary ventricular function) ≥1 point p/y |
isolated CHD: ES/TGA/TOF/LSOD/ASD/VSD/AVSD/Cyanotic non-ES/EA/other |
risk factor |
|
1351 |
Cardiac events before pregnancy |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/PDA/MVS/MP/BAV/AS/PS/DPA/TS/TOF/EA/NA/TGA/TAPVD |
risk factor |
|
1352 |
New York Heart Association(NYHA) functional class >II |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/PDA/MVS/MP/BAV/AS/PS/DPA/TS/TOF/EA/NA/TGA/TAPVD |
risk factor |
|
1353 |
Moderate or severe PAH (Systolic pressure ≥50 mm Hg.) |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/PDA/MVS/MP/BAV/AS/PS/DPA/TS/TOF/EA/NA/TGA/TAPVD |
risk factor |
|
1354 |
Left heart obstruction |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/PDA/MVS/MP/BAV/AS/PS/DPA/TS/TOF/EA/NA/TGA/TAPVD |
risk factor |
|
1355 |
Oxygen saturation <90% |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/PDA/MVS/MP/BAV/AS/PS/DPA/TS/TOF/EA/NA/TGA/TAPVD |
risk factor |
|
1386 |
cardiac related hospitalizations |
isolated CHD: TOF/EA/ASD/L-TGA/D-TGA/PS/other |
risk factor |
|
1387 |
cardiac interventions |
isolated CHD: TOF/EA/ASD/L-TGA/D-TGA/PS/other |
risk factor |
|
1420 |
metabolic syndrome criteria met(after matched control) |
isolated CHD: TOF/other/D-TGA/NA/VSD/AVSD/ccTGA/TAPVR/EA/ASD/CACA/EIS/PA, IVS/TA |
risk factor |
|
1422 |
long donor heart ischemic time |
isolated CHD/non-isolated CHD: DORV, VSD/TOF/TGA/DOLV, PS/DILV, TGA, PS/ALVT/EA/DILV, VSD, PS/DORV, TGA, VSD, PS/ccTGA/VSD, CoA, PLSVC/PA, VSD/TGA, VSD/DORV, VSD, ASD, PS |
risk factor (article mentioned) |
|
1423 |
right ventricular assist device(RVAD) |
isolated CHD/non-isolated CHD: DORV, VSD/TOF/TGA/DOLV, PS/DILV, TGA, PS/ALVT/EA/DILV, VSD, PS/DORV, TGA, VSD, PS/ccTGA/VSD, CoA, PLSVC/PA, VSD/TGA, VSD/DORV, VSD, ASD, PS |
risk factor (article mentioned) |
|
1424 |
cTnT |
isolated CHD/non-isolated CHD: HLHS/AVSD/PA, IVS/HRHS |
risk factor (article mentioned) |
|
1425 |
NT pro-BNP |
isolated CHD/non-isolated CHD: HLHS/AVSD/PA, IVS/HRHS |
risk factor (article mentioned) |
|
1428 |
risk of neonatal death according to the cord blood concentrations of NT pro-BNP and cTnT |
isolated CHD/non-isolated CHD: HLHS/AVSD/PA, IVS/HRHS |
risk factor (article mentioned) |
|
1464 |
mortality |
isolated CHD/non-isolated CHD: C-CHD/non C-CHD |
risk factor |
|
1465 |
previous cardiac surgery |
isolated CHD/non-isolated CHD: C-CHD/non C-CHD |
risk factor |
|
1495 |
serum glucose |
isolated CHD: TOF |
risk factor |
|
1497 |
proportion of male |
isolated CHD/non-isolated CHD: ASD/TOF/VSD/DORV/PDA/EA/AVSD/L-TGA/SV/PA, VSD, MAPCA/TA/PS/TAS/D-TGA |
risk factor |
|
1498 |
current smoking |
isolated CHD/non-isolated CHD: ASD/TOF/VSD/DORV/PDA/EA/AVSD/L-TGA/SV/PA, VSD, MAPCA/TA/PS/TAS/D-TGA |
risk factor |
|
1500 |
problematic alcohol use |
isolated CHD/non-isolated CHD: ASD/TOF/VSD/DORV/PDA/EA/AVSD/L-TGA/SV/PA, VSD, MAPCA/TA/PS/TAS/D-TGA |
risk factor |
|
1501 |
with exercise |
isolated CHD/non-isolated CHD: ASD/TOF/VSD/DORV/PDA/EA/AVSD/L-TGA/SV/PA, VSD, MAPCA/TA/PS/TAS/D-TGA |
risk factor |
|
1502 |
surgically corrected ACHD |
isolated CHD/non-isolated CHD: ASD/TOF/VSD/DORV/PDA/EA/AVSD/L-TGA/SV/PA, VSD, MAPCA/TA/PS/TAS/D-TGA |
risk factor |
|
1504 |
age |
isolated CHD/non-isolated CHD: ASD/TOF/VSD/DORV/PDA/EA/AVSD/L-TGA/SV/PA, VSD, MAPCA/TA/PS/TAS/D-TGA |
risk factor |
|
1505 |
proportion of male |
isolated CHD/non-isolated CHD: ASD/TOF/VSD/DORV/PDA/EA/AVSD/L-TGA/SV/PA, VSD, MAPCA/TA/PS/TAS/D-TGA |
risk factor |
|
1506 |
current smoking |
isolated CHD/non-isolated CHD: ASD/TOF/VSD/DORV/PDA/EA/AVSD/L-TGA/SV/PA, VSD, MAPCA/TA/PS/TAS/D-TGA |
risk factor |
|
1508 |
problematic alcohol use |
isolated CHD/non-isolated CHD: ASD/TOF/VSD/DORV/PDA/EA/AVSD/L-TGA/SV/PA, VSD, MAPCA/TA/PS/TAS/D-TGA |
risk factor |
|
1509 |
exercise |
isolated CHD/non-isolated CHD: ASD/TOF/VSD/DORV/PDA/EA/AVSD/L-TGA/SV/PA, VSD, MAPCA/TA/PS/TAS/D-TGA |
risk factor |
|
1512 |
log10 NT pro-BNP |
isolated CHD: PA/ccTGA/VSD/NA/SV/ES/PAH/CoA/EA/TGA/TOF/ASD/AVSD/TA/PS/AVD |
risk factor |
|
1514 |
GDF-15 level in age |
isolated CHD/non-isolated CHD: AS/AC/TOF/TGA/ccTGA/NA/PAH/TGA, VSD, DORV |
risk factor |
|
1523 |
GDF-15 |
isolated CHD/non-isolated CHD: AS/AC/TOF/TGA/ccTGA/NA/PAH/TGA, VSD, DORV |
risk factor |
|
1525 |
Age |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/TGA/ccTGA/EA/ES/other |
risk factor(article mentioned) |
|
1526 |
Gender (% female) |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/TGA/ccTGA/EA/ES/other |
risk factor(article mentioned) |
|
1527 |
Complexity--Complex disease |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/TGA/ccTGA/EA/ES/other |
risk factor(article mentioned) |
|
1528 |
NYHA class--Class III |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/TGA/ccTGA/EA/ES/other |
risk factor(article mentioned) |
|
1529 |
NYHA class--Class IV |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/TGA/ccTGA/EA/ES/other |
risk factor(article mentioned) |
|
1540 |
Age (per decade) |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/TGA/ccTGA/EA/ES/other |
risk factor(Univariate analysis) |
|
1541 |
Female sex |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/TGA/ccTGA/EA/ES/other |
risk factor |
|
1542 |
NYHA class>2 |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/TGA/ccTGA/EA/ES/other |
risk factor(Univariate analysis) |
|
1543 |
Complex disease |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/TGA/ccTGA/EA/ES/other |
risk factor |
|
1544 |
Anti-arrhythmic therapy |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/TGA/ccTGA/EA/ES/other |
risk factor(Univariate analysis) |
|
1545 |
Heart failure medication |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/TGA/ccTGA/EA/ES/other |
risk factor(Univariate analysis) |
|
1546 |
survival propability |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/TGA/ccTGA/EA/ES/other |
risk factor |
|
1563 |
Dextrocardia |
isolated CHD/non-isolated CHD: TGA, VSD/PA, VSD/AVSD, ccTGA, MA/CoA, VSD/D-TGA, VSD/ccTGA/DORV, MA, PS/TAPVR |
risk factor |
|
1564 |
Correlation between socioeconomic status and Total IQ |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/HAA, CoA/TGA/TOF/PA/DORV/TAPVD/HLHS/DILV/TA/other |
risk factor |
|
1565 |
Correlation between RACHS-1 score and total IQ |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/HAA, CoA/TGA/TOF/PA/DORV/TAPVD/HLHS/DILV/TA/other |
risk factor |
|
1566 |
Correlation between antegrade cerebral perfusion and total IQ |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/HAA, CoA/TGA/TOF/PA/DORV/TAPVD/HLHS/DILV/TA/other |
risk factor |
|
1567 |
Correlation between Length of ICU stay (d) and Total IQ |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/HAA, CoA/TGA/TOF/PA/DORV/TAPVD/HLHS/DILV/TA/other |
risk factor |
|
1568 |
Correlation between RACHS-1 score and M-ABC-2 percentile rank |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/HAA, CoA/TGA/TOF/PA/DORV/TAPVD/HLHS/DILV/TA/other |
risk factor |
|
1572 |
Intercept(Regression of maximum exercise time to independent variables) |
NA: NA |
risk factor |
|
1576 |
Maximum HR(heart rate)(Regression of maximum exercise time to independent variables) |
NA: NA |
risk factor |
|
1577 |
Intercept(Regression of VE/VCO2 at peak exercise to independent variables) |
NA: NA |
risk factor |
|
1578 |
Severity(Regression of VE/VCO2 at peak exercise to independent variables) |
NA: NA |
risk factor |
|
1582 |
age less than 1 year(risk factors for early-phase mortality) |
isolated CHD: HLHS/other |
risk factor |
|
1583 |
prolonged cardiopulmonary bypass(risk factors for early-phase mortality) |
isolated CHD: HLHS/other |
risk factor |
|
1584 |
age more than 1 year(risk factors for late-phase mortality) |
isolated CHD: HLHS/other |
risk factor |
|
1585 |
donor-recipient race mismatch(risk factors for late-phase mortality) |
isolated CHD: HLHS/other |
risk factor |
|
1601 |
Depressive symptoms--Yes/No |
isolated CHD/non-isolated CHD: VSD/ASD/VSD/PDA/BAV/TOF/CoA/PV/SAS/AVC/ccTGA/UVA/PA/other |
risk factor |
|
1602 |
History of smoking tobacco use--Yes/No |
isolated CHD/non-isolated CHD: VSD/ASD/VSD/PDA/BAV/TOF/CoA/PV/SAS/AVC/ccTGA/UVA/PA/other |
risk factor |
|
1603 |
Advised to seek/history of mental health counseling--Yes/No |
isolated CHD/non-isolated CHD: VSD/ASD/VSD/PDA/BAV/TOF/CoA/PV/SAS/AVC/ccTGA/UVA/PA/other |
risk factor |
|
1615 |
odd ratios of CHD by Total-Age (0-<1 months) |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
risk factor |
|
1616 |
odd ratios of CHD by Total-Age (1-<2 months) |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
risk factor |
|
1617 |
odd ratios of CHD by Total-Age (2-<3 months) |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
risk factor |
|
1618 |
odd ratios of CHD by Total- Birthweight(<2500 g) |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
risk factor |
|
1619 |
odd ratios of CHD by Total- Birthweight( 2500-<3000g) |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
risk factor |
|
1620 |
odd ratios of CHD by Total- Gestational age (37 weeks) |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
risk factor |
|
1621 |
odd ratios of CHD by Maternal characteristics Age (≥40 years) |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
risk factor |
|
1622 |
odd ratios of CHD by Pregnant infection |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
risk factor |
|
1623 |
odd ratios of CHD by Pregnancy-induced hypertension |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
risk factor |
|
1624 |
odd ratios of CHD by Gestational diabetes |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
risk factor |
|
1625 |
odd ratios of CHD by History of mother with CHD |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
risk factor |
|
1626 |
odd ratios of CHD by History of father with CHD (Yes) |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
risk factor |
|
1627 |
odd ratios of CHD by Education of mother (<13 years) |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
risk factor |
|
1628 |
odd ratios of CHD by Family income (<1000 yuan/month) |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
risk factor |
|
1685 |
SNPs in mothers: MTHFR gene rs1801131:CC |
NA: NA |
risk factor |
|
1686 |
SNPs in mothers: MTHFR gene rs1801131:AA+AC |
NA: NA |
risk factor |
|
1693 |
SNPs in children: MTHFR gene rs1801131:AC |
NA: NA |
risk factor |
|
1694 |
SNPs in children: MTHFR gene rs1801131:AC+CC |
NA: NA |
risk factor |
|
1695 |
SNPs in children: MTHFR gene rs1801131:AA:AC:CC |
NA: NA |
risk factor |
|
1759 |
Bradyarrhythmia receiving intervention during entire postoperative course |
NA: NA |
risk factor |
|
1837 |
longer aortic cross clamping time |
isolated CHD/non-isolated CHD: HOCM, SAS, DCRV/VSD/D-TGA, VSD, PS, TVD/MS/DORV, TGA, VSD/ccTGA, PA, VSD/AVSD/AA, VSD, ASD, CoA |
risk factor(article mentioned) |
|
1839 |
surgical procedures including closure of VSD |
isolated CHD/non-isolated CHD: HOCM, SAS, DCRV/VSD/D-TGA, VSD, PS, TVD/MS/DORV, TGA, VSD/ccTGA, PA, VSD/AVSD/AA, VSD, ASD, CoA |
risk factor |
|
1853 |
age |
NA: NA |
risk factor |
|
1854 |
age at ICD implantation |
NA: NA |
risk factor |
|
1855 |
appropriate ICD shocks |
NA: NA |
risk factor |
|
1858 |
correlation between CHD(>28 days) and childhood stroke |
NA: NA |
risk factor |
|
1859 |
History of CHD repair surgery |
NA: NA |
risk factor |
|
1860 |
Cyanotic heart disease |
NA: C-CHD |
risk factor |
|
1863 |
Time from surgery(not in prior 14 days) |
NA: NA |
risk factor |
|
1865 |
mental stress during early pregnancy |
isolated CHD: ASD/VSD/other |
risk factor |
|
1866 |
pregnancy malnutrition during pregnancy |
isolated CHD: ASD/VSD/other |
risk factor |
|
1867 |
with abnormal childbearing history |
isolated CHD: ASD/VSD/other |
risk factor |
|
1869 |
diagnosis of single-ventricle heart defect |
isolated CHD: HLHS/TA/HRV/other/PS/CoA/TOF/IAA/PA/TGA/TA/AVS/EA/DORV |
risk factor |
|
1873 |
VSD |
isolated CHD: VSD |
risk factor |
|
1874 |
PDA |
isolated CHD: PDA |
risk factor |
|
1875 |
combined lesions |
non-isolated CHD: NA |
risk factor |
|
1877 |
HFSS with arrhythmia requiring treatment |
isolated CHD/non-isolated CHD: TOF/RV/EA/other |
risk factor |
|
1878 |
HFSS with CV hospitalizations |
isolated CHD/non-isolated CHD: TOF/RV/EA/other |
risk factor |
|
1879 |
HFSS with the composite |
isolated CHD/non-isolated CHD: TOF/RV/EA/other |
risk factor |
|
1891 |
Procedure-type categories 3 |
isolated CHD: PDA/ASD/PV/PAS/TGA/CoA/PFO/AVS/PA/TOF/DORV/UVH/VSD/other |
risk factor |
|
1892 |
Procedure-type categories 4 |
isolated CHD: PDA/ASD/PV/PAS/TGA/CoA/PFO/AVS/PA/TOF/DORV/UVH/VSD/other |
risk factor |
|
1926 |
the history of aorto-pulmonary shunt |
isolated CHD: TOF/SV/AC/IAA/VSD/ASD/TGA/EA/ccTGA/TA/other |
risk factor |
|
1927 |
the direct aortic surgery |
isolated CHD: TOF/SV/AC/IAA/VSD/ASD/TGA/EA/ccTGA/TA/other |
risk factor |
|
1930 |
hospitalization stay length |
isolated CHD: VSD/ASD/PS/PDA/TOF/other |
risk factor |
|
1931 |
combined use of antibiotics |
isolated CHD: VSD/ASD/PS/PDA/TOF/other |
risk factor |
|
1932 |
systemic use of hormones |
isolated CHD: VSD/ASD/PS/PDA/TOF/other |
risk factor |
|
1933 |
mechanical ventilation |
isolated CHD: VSD/ASD/PS/PDA/TOF/other |
risk factor |
|
1934 |
catheter indwelling |
isolated CHD: VSD/ASD/PS/PDA/TOF/other |
risk factor |
|
1950 |
predictor of unscheduled hospitalization: SV systolic function |
isolated CHD/non-isolated CHD: TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
risk factor |
|
1952 |
predictor of unscheduled hospitalization: Diuretics |
isolated CHD/non-isolated CHD: TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
risk factor |
|
1953 |
predictor of unscheduled hospitalization: Anti-coagulant |
isolated CHD/non-isolated CHD: TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
risk factor |
|
1954 |
predictor of unscheduled hospitalization: ACEI/ARB |
isolated CHD/non-isolated CHD: TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
risk factor |
|
1955 |
predictor of unscheduled hospitalization: use of β blocker |
isolated CHD/non-isolated CHD: TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
risk factor |
|
1959 |
predictor of unscheduled hospitalization: low glucose(<84) |
isolated CHD/non-isolated CHD: TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
risk factor |
|
1960 |
predictor of unscheduled hospitalization: High AUC PG(>6.165) |
isolated CHD/non-isolated CHD: TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
risk factor |
|
1961 |
predictor of unscheduled hospitalization: IGT/DM vs NGT |
isolated CHD/non-isolated CHD: TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
risk factor |
|
1963 |
predictor of mortality: NYHA class |
isolated CHD/non-isolated CHD: TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
risk factor |
|
1966 |
predictor of mortality: Diuretics |
isolated CHD/non-isolated CHD: TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
risk factor |
|
1967 |
predictor of mortality: Anti-coagulant |
isolated CHD/non-isolated CHD: TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
risk factor |
|
1968 |
predictor of mortality: low glucose(<80) |
isolated CHD/non-isolated CHD: TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
risk factor |
|
1969 |
FPG |
isolated CHD/non-isolated CHD: TA/UVH/VSD/DORV/TGA/MA/CoA, IAA |
risk factor(Univariate analysis) |
|
1970 |
symptomatic ACHD with lower FPG |
isolated CHD/non-isolated CHD: TA/UVH/VSD/DORV/TGA/MA/CoA, IAA |
risk factor |
|
1971 |
symptomatic ACHD with lower FPG |
isolated CHD/non-isolated CHD: TA/UVH/VSD/DORV/TGA/MA/CoA, IAA |
risk factor |
|
1995 |
serum uric acid(male patients)(mg/dl) |
isolated CHD: VSD/TOF/ASD/CoA/PS/AVSD/TGA/AS/BAV/DORV/UVH/EA/PA/Ductus/TA/PTA/SAM/MVP/PVA/other |
risk factor |
|
1996 |
serum creatinine(male patients)(mg/dl) |
isolated CHD: VSD/TOF/ASD/CoA/PS/AVSD/TGA/AS/BAV/DORV/UVH/EA/PA/Ductus/TA/PTA/SAM/MVP/PVA/other |
risk factor |
|
2000 |
CRP (male patients)(mg/dl) |
isolated CHD: VSD/TOF/ASD/CoA/PS/AVSD/TGA/AS/BAV/DORV/UVH/EA/PA/Ductus/TA/PTA/SAM/MVP/PVA/other |
risk factor |
|
2007 |
CRP (female patients)(mg/dl) |
isolated CHD: VSD/TOF/ASD/CoA/PS/AVSD/TGA/AS/BAV/DORV/UVH/EA/PA/Ductus/TA/PTA/SAM/MVP/PVA/other |
risk factor |
|
2012 |
LVID/BSA |
isolated CHD/non-isolated CHD: VSD/PDA/VSD, PDA/CoA/VSD/PDA |
risk factor |
|
2037 |
Relatvie risk for maternal distress 6 months |
isolated CHD/non-isolated CHD: non C-CHD/C-CHD/other |
risk factor |
|
2038 |
mean for maternal distress 18 months |
isolated CHD/non-isolated CHD: non C-CHD/C-CHD/other |
risk factor |
|
2040 |
Relatvie risk for maternal distress 36 months |
isolated CHD/non-isolated CHD: non C-CHD/C-CHD/other |
risk factor |
|
2042 |
relative risk for Child fussiness 6 months |
isolated CHD/non-isolated CHD: non C-CHD/C-CHD/other |
risk factor |
|
2043 |
mean for Child internalizing problems 18 months |
isolated CHD/non-isolated CHD: non C-CHD/C-CHD/other |
risk factor |
|
2044 |
relative risk for Child internalizing problems 36 months |
isolated CHD/non-isolated CHD: non C-CHD/C-CHD/other |
risk factor |
|
2051 |
hippocampi vulume |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
2052 |
corpus callosum vulume |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
2108 |
correlation between early open-heart surgery and ADHD screening score |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
2115 |
cardiac surgery |
isolated CHD: C-CHD/ECD/LSL/RSL/PDA/VSD/ASD |
risk factor |
|
2116 |
cyanotic CHD |
isolated CHD: C-CHD/ECD/LSL/RSL/PDA/VSD/ASD |
risk factor |
|
2117 |
Endocardial cushion defects(ECD) |
isolated CHD: C-CHD/ECD/LSL/RSL/PDA/VSD/ASD |
risk factor |
|
2118 |
Left sided lesions(LSL) |
isolated CHD: C-CHD/ECD/LSL/RSL/PDA/VSD/ASD |
risk factor |
|
2119 |
age |
isolated CHD: C-CHD/ECD/LSL/RSL/PDA/VSD/ASD |
risk factor |
|
2130 |
SV and dialysis |
NA: NA |
risk factor(article mentioned) |
|
2131 |
Creatinine>1.5 mg/dL |
NA: NA |
risk factor(article mentioned) |
|
2132 |
Dialysis |
NA: NA |
risk factor(article mentioned) |
|
2133 |
Ventricular assist and dialysis |
NA: NA |
risk factor(article mentioned) |
|
2134 |
Ventricular assist and creatinine>1.5 mg/dL |
NA: NA |
risk factor(article mentioned) |
|
2135 |
SV and reoperation |
NA: NA |
risk factor(article mentioned) |
|
2136 |
Previous operations>2 |
NA: NA |
risk factor(article mentioned) |
|
2137 |
SV and ventricular assist |
NA: NA |
risk factor(article mentioned) |
|
2138 |
SV and dialysis |
NA: NA |
risk factor |
|
2139 |
creatinine>1.5 mg/dL |
NA: NA |
risk factor |
|
2162 |
ADAMTS-13 activity (%) |
isolated CHD: TOF/PA/VSD/UVH |
risk factor |
|
2164 |
preoperative ADAMTS-13 activity of <64.6% |
isolated CHD: TOF/PA/VSD/UVH |
risk factor |
|
2166 |
cardiopulmonary bypass (CPB) |
isolated CHD: TOF/PA/VSD/UVH |
risk factor |
|
2236 |
CHD cases of mother(Indoor renovation) |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/CoA/IAA/other |
risk factor |
|
2237 |
Indoor renovation--Complex malformation |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/CoA/IAA/other |
risk factor |
|
2238 |
Indoor renovation--Isolated Cardiac defect |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/CoA/IAA/other |
risk factor |
|
2239 |
Indoor renovation--Conotruncal defect |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/CoA/IAA/other |
risk factor |
|
2240 |
Indoor renovation--Anomalous venous return |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/CoA/IAA/other |
risk factor |
|
2241 |
Indoor renovation--Others Subtype for isolated cardiac defect |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/CoA/IAA/other |
risk factor |
|
2242 |
Interval between renovation and moving-in(<1 months)--3 months before pregnancy |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/CoA/IAA/other |
risk factor |
|
2243 |
Interval between renovation and moving-in(<1 months in first trimester) |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/CoA/IAA/other |
risk factor |
|
2246 |
Ischemic time >4 hours |
isolated CHD: TGA/VSD/ASD/TOF/other |
risk factor |
|
2270 |
Average mean pressure pre-induction |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
2271 |
Average diastolic pressure pre-induction |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
2272 |
Difference between systolic pressure pre- and post induction |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
2273 |
Difference between mean pressure pre and post induction |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
2274 |
Difference between diastolic pressure pre- and post induction |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
2275 |
Incidence of level 3–5 adverse event(AE) with different age |
NA: NA |
risk factor |
|
2276 |
Incidence of level 3–5 adverse event(AE) with different Hemodynamic risk factors |
NA: NA |
risk factor |
|
2277 |
Incidence of level 3–5 adverse event(AE) with different Hemodynamic risk factors |
NA: NA |
risk factor |
|
2278 |
Incidence of level 3–5 adverse event(AE) with Procedure type risk group |
NA: NA |
risk factor |
|
2279 |
Incidence of level 3–5 adverse event(AE) with Procedure type risk group |
NA: NA |
risk factor |
|
2280 |
Incidence of level 3–5 adverse event(AE) with Procedure type risk group |
NA: NA |
risk factor |
|
2281 |
Any adverse events: Incidence of AE in different operator years in practice |
NA: NA |
risk factor |
|
2282 |
Incidence of AE(Level 3–5 Adverse Events) in different Operator years in practice |
NA: NA |
risk factor |
|
2283 |
Incidence of AE(Level 3–5 Adverse Events) in different Operator years in practice |
NA: NA |
risk factor |
|
2284 |
Incidence of preventable AE in different Operator years in practice |
NA: NA |
risk factor |
|
2285 |
Incidence of AE in different operator volume (cases/year) |
NA: NA |
risk factor |
|
2292 |
Cardiothoracic ratio--In Relation to Lung Function |
isolated CHD/non-isolated CHD: ASD/VSD/AC/TGA/AVSD/ccTGA/EA/TOF/other |
risk factor |
|
2293 |
Moderate to severe scoliosis--In Relation to Lung Function |
isolated CHD/non-isolated CHD: ASD/VSD/AC/TGA/AVSD/ccTGA/EA/TOF/other |
risk factor |
|
2294 |
Diaphragm palsy--In Relation to Lung Function |
isolated CHD/non-isolated CHD: ASD/VSD/AC/TGA/AVSD/ccTGA/EA/TOF/other |
risk factor |
|
2300 |
Surgical history:Previous thoracotomy--In Relation to Lung Function |
isolated CHD/non-isolated CHD: ASD/VSD/AC/TGA/AVSD/ccTGA/EA/TOF/other |
risk factor |
|
2315 |
6-MWD, m |
isolated CHD: VSD/TA/PDA/TGA |
risk factor |
|
2318 |
cardiac events before pregnancy |
isolated CHD: ASD/VSD/PDA/TOF/CVI/MVP |
risk factor |
|
2319 |
New York Heart Association functional class greater than II |
isolated CHD: ASD/VSD/PDA/TOF/CVI/MVP |
risk factor |
|
2320 |
oxygen saturation below 90% |
isolated CHD: ASD/VSD/PDA/TOF/CVI/MVP |
risk factor |
|
2321 |
left ventricular obstruction (aorta stenosis) |
isolated CHD: ASD/VSD/PDA/TOF/CVI/MVP |
risk factor |
|
2322 |
New York Heart Association functional class greater than II |
isolated CHD: ASD/VSD/PDA/TOF/CVI/MVP |
risk factor |
|
2323 |
oxygen saturation below 90% |
isolated CHD: ASD/VSD/PDA/TOF/CVI/MVP |
risk factor |
|
2324 |
pulmonary arterial hypertension (systolic pressure ≥50 mm Hg) |
isolated CHD: ASD/VSD/PDA/TOF/CVI/MVP |
risk factor |
|
2328 |
Percent of LCHB for patinets with duration of postoperative TCHB ≥7 days |
NA: NA |
risk factor |
|
2343 |
history of >1 thoracotomies |
isolated CHD/non-isolated CHD: CoA/TOF/LVOTO/ASD, VSD, AVSD/SV/D-TGA/ccTGA/EA/PVS |
risk factor |
|
2344 |
history of atrial arrhythmias |
isolated CHD/non-isolated CHD: CoA/TOF/LVOTO/ASD, VSD, AVSD/SV/D-TGA/ccTGA/EA/PVS |
risk factor |
|
2345 |
Spirometry suggestive of restrictive lung disease |
isolated CHD/non-isolated CHD: CoA/TOF/LVOTO/ASD, VSD, AVSD/SV/D-TGA/ccTGA/EA/PVS |
risk factor |
|
2348 |
History of previous surgery |
isolated CHD/non-isolated CHD: CoA/TOF/LVOTO/ASD, VSD, AVSD/SV/D-TGA/ccTGA/EA/PVS |
risk factor |
|
2349 |
Low heart rate reserve (<70 bpm) |
isolated CHD/non-isolated CHD: CoA/TOF/LVOTO/ASD, VSD, AVSD/SV/D-TGA/ccTGA/EA/PVS |
risk factor |
|
2383 |
Prevalence of first and second-degree relatives |
isolated CHD/non-isolated CHD: ASD/VSD/VSD, ASD, PDA/VSD, PDA, PAH/TOF/HLHS/CoA/PA, VSD, PS/PS, RVOTO/ASD, MRMV, PMT/PA, VSD/SA, SV, CAVC, HLHS/PDA/CAF/VSD, RVOTO, CoA/AS |
risk factor(article mentioned) |
|
2384 |
Prevalence of first-degree relatives |
isolated CHD/non-isolated CHD: ASD/VSD/VSD, ASD, PDA/VSD, PDA, PAH/TOF/HLHS/CoA/PA, VSD, PS/PS, RVOTO/ASD, MRMV, PMT/PA, VSD/SA, SV, CAVC, HLHS/PDA/CAF/VSD, RVOTO, CoA/AS |
risk factor(article mentioned) |
|
2386 |
age |
NA: NA |
risk factor |
|
2387 |
reduced (0.3-0.5) systemic left ventricle ejection fraction(LVEF) |
NA: NA |
risk factor |
|
2392 |
CPB(the duration of cardiopulmonary bypass) |
NA: NA |
risk factor |
|
2410 |
use of cardiopulmonary bypass of one month of age and younger |
NA: NA |
risk factor(article mentioned) |
|
2425 |
risk factor for AKI: age |
NA: NA |
risk factor(article mentioned) |
|
2426 |
risk factor for acute kidney failure: age |
NA: NA |
risk factor(article mentioned) |
|
2428 |
cardiopulmonary bypass time |
NA: NA |
risk factor(article mentioned) |
|
2429 |
Cardiopulmonary bypass of 1 month of age and younger |
NA: NA |
risk factor(article mentioned) |
|
2464 |
Factor related the surgical success rate and complications for ASD: age |
isolated CHD: ASD |
risk factor |
|
2468 |
Factor related the surgical success rate and comlications for VSD: distance from VSD to AV |
isolated CHD: VSD |
risk factor |
|
2469 |
Factor related the surgical success rate and comlications for VSD: pulmonary arterial hypertension(PAH) |
isolated CHD: VSD |
risk factor |
|
2471 |
Risk factor related the occurrence of complications for VSD: device size |
isolated CHD: VSD |
risk factor |
|
2473 |
Risk factor related the occurrence of complications for PBPV: PS degree |
isolated CHD: PS |
risk factor |
|
2475 |
risk factors for all the events (early and late death): urgency status |
isolated CHD/non-isolated CHD: UVH/TA/DILV, PA/DILV, PS/DILV/UVH, TGA/HLHS/DOLV/UAVC/PA, IVS/TOF/PA, VSD/TGA/TGA/AVC/EA/SD/MD/AD, CoA/CoA, VSD/TAPVR/CACA/TOF, AVC/MAD |
risk factor |
|
2476 |
risk factors for all the events (early and late death): preoperative mechanical ventilation |
isolated CHD/non-isolated CHD: UVH/TA/DILV, PA/DILV, PS/DILV/UVH, TGA/HLHS/DOLV/UAVC/PA, IVS/TOF/PA, VSD/TGA/TGA/AVC/EA/SD/MD/AD, CoA/CoA, VSD/TAPVR/CACA/TOF, AVC/MAD |
risk factor |
|
2510 |
BMI (3 categories) |
NA: NA |
risk factor |
|
2513 |
goiter |
NA: NA |
risk factor |
|
2514 |
BMI 3 catergories (reference=BMI>25) |
NA: NA |
risk factor |
|
2526 |
correlation between BMI and higher AIT risk |
NA: NA |
risk factor |
|
2528 |
Risk factor of AIT: BMI<21 (ref=BMI>25) |
NA: NA |
risk factor |
|
2529 |
Risk factor of AIT: goiter |
NA: NA |
risk factor |
|
2542 |
association between double BNP level with heart failure |
isolated CHD/non-isolated CHD: HLHS/MA/MS/AA/MS/AS/RDACD/DORV/IAA, VSD, SLV/AS, PS, LV/AS, L-TGA, PS, SLV/TA/PA, IVS/DILV/D-TGA, MV, RV/PS, RV |
risk factor |
|
2543 |
correlation between BNP with heart failure in single ventricle group |
isolated CHD/non-isolated CHD: HLHS/MA/MS/AA/MS/AS/RDACD/DORV/IAA, VSD, SLV/AS, PS, LV/AS, L-TGA, PS, SLV/TA/PA, IVS/DILV/D-TGA, MV, RV/PS, RV |
risk factor |
|
2544 |
correlation between BNP with heart failure in all patients with Stage II |
isolated CHD/non-isolated CHD: HLHS/MA/MS/AA/MS/AS/RDACD/DORV/IAA, VSD, SLV/AS, PS, LV/AS, L-TGA, PS, SLV/TA/PA, IVS/DILV/D-TGA, MV, RV/PS, RV |
risk factor |
|
2545 |
correlation between double NT-proBNP with heart failure |
isolated CHD/non-isolated CHD: HLHS/MA/MS/AA/MS/AS/RDACD/DORV/IAA, VSD, SLV/AS, PS, LV/AS, L-TGA, PS, SLV/TA/PA, IVS/DILV/D-TGA, MV, RV/PS, RV |
risk factor |
|
2546 |
correlation between double NT-proBNP with heart failure in single ventricle group |
isolated CHD/non-isolated CHD: HLHS/MA/MS/AA/MS/AS/RDACD/DORV/IAA, VSD, SLV/AS, PS, LV/AS, L-TGA, PS, SLV/TA/PA, IVS/DILV/D-TGA, MV, RV/PS, RV |
risk factor |
|
2553 |
correlation between exceeding CTR increasing and the risk of mortality |
isolated CHD/non-isolated CHD: PDA/AC/VSD/AS, TGA/TGA/ASD/ccTGA/ASD/TOF/EIS/EA |
risk factor |
|
2554 |
correlation between mild CTR increasing and the risk of mortality |
isolated CHD/non-isolated CHD: PDA/AC/VSD/AS, TGA/TGA/ASD/ccTGA/ASD/TOF/EIS/EA |
risk factor |
|
2555 |
correlation between NYHA class and the risk of mortality |
isolated CHD/non-isolated CHD: PDA/AC/VSD/AS, TGA/TGA/ASD/ccTGA/ASD/TOF/EIS/EA |
risk factor |
|
2556 |
correlation between NYHA class and the risk of mortality |
isolated CHD/non-isolated CHD: PDA/AC/VSD/AS, TGA/TGA/ASD/ccTGA/ASD/TOF/EIS/EA |
risk factor |
|
2557 |
correlation between NYHA class and the risk of mortality |
isolated CHD/non-isolated CHD: PDA/AC/VSD/AS, TGA/TGA/ASD/ccTGA/ASD/TOF/EIS/EA |
risk factor |
|
2585 |
association of plasma VWF:Ag with the risk of death adjusted for : gender |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2586 |
association of plasma VWF:Ag with the risk of death adjusted for : clinical presentation |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2587 |
association of plasma VWF:Ag with the risk of death adjusted for : functional class |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2588 |
association of plasma VWF:Ag with the risk of death adjusted for : resting SpO2 |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2589 |
association of plasma VWF:Ag with the risk of death adjusted for : 6-min walk SpO2 |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2590 |
association of plasma VWF:Ag with the risk of death adjusted for : 6-min walk distance |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2591 |
association of plasma VWF:Ag with the risk of death adjusted for : Hematocrit |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2592 |
association of plasma VWF:Ag with the risk of death adjusted for : PAH advanced therapy |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2593 |
association of plasma VWF:Ag with the risk of death adjusted for : Duration of treatment |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2594 |
association of plasma VWF:Ag with the risk of death adjusted for : PAP systolic |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2595 |
association of plasma VWF:Ag with the risk of death adjusted for : statin |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2596 |
association of plasma VWF:Ag with the risk of death adjusted for : age |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2597 |
association of plasma VWF:Ag with the risk of death adjusted for : gender |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2598 |
association of plasma VWF:Ag with the risk of death adjusted for : clinical presentation |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2599 |
association of plasma VWF:Ag with the risk of death adjusted for : functional class |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2600 |
association of plasma VWF:Ag with the risk of death adjusted for : resting SpO2 |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2601 |
association of plasma VWF:Ag with the risk of death adjusted for : 6-min walk SpO2 |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2602 |
association of plasma VWF:Ag with the risk of death adjusted for : 6-min walk distance |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2603 |
association of plasma VWF:Ag with the risk of death adjusted for : Hematocrit |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2604 |
association of plasma VWF:Ag with the risk of death adjusted for : PAH advanced therapy |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2605 |
association of plasma VWF:Ag with the risk of death adjusted for : Duration of treatment |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2606 |
association of plasma VWF:Ag with the risk of death adjusted for : PAP systolic |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2607 |
association of plasma VWF:Ag with the risk of death adjusted for : statin |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2633 |
age < 1 month |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
risk factor |
|
2634 |
gender |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
risk factor |
|
2635 |
use of cardiopulmonary bypass |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
risk factor |
|
2637 |
Risk Adjusted classification for Congenital Heart Surgery, version 1, > 3 |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
risk factor |
|
2638 |
Initial lactate (mmol/L) |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
risk factor |
|
2639 |
Dopamine |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
risk factor |
|
2640 |
Epinephrine |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
risk factor |
|
2641 |
Milrinone |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
risk factor |
|
2643 |
age < 1 month |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
risk factor |
|
2645 |
use of cardiopulmonary bypass |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
risk factor |
|
2647 |
Risk Adjusted classification for Congenital Heart Surgery, version 1, > 3 |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
risk factor |
|
2649 |
Dopamine |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
risk factor |
|
2650 |
Epinephrine |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
risk factor |
|
2651 |
Milrinone |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
risk factor |
|
2652 |
age < 1 month |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
risk factor |
|
2653 |
use of cardiopulmonary bypass |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
risk factor |
|
2655 |
Milrinone |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
risk factor |
|
2662 |
association between RV and pulmonary dynamics with the distance walked in 6 minutes: Body surface area |
NA: NA |
risk factor |
|
2667 |
association between RV and pulmonary dynamics with the distance walked in 6 minutes: Indexed pulmonary blood flow |
NA: NA |
risk factor |
|
2668 |
association between RV and pulmonary dynamics with the distance walked in 6 minutes: Stroke volume |
NA: NA |
risk factor |
|
2670 |
association between RV and pulmonary dynamics with the distance walked in 6 minutes: Pulmonary artery ejection time |
NA: NA |
risk factor |
|
2672 |
association between RV and pulmonary dynamics with the distance walked in 6 minutes: Cardiac index |
NA: NA |
risk factor |
|
2727 |
≤ 2.5 kg at operation |
isolated CHD: PA/VSD/ASD/TA/AVSD/TAPVC/other |
risk factor |
|
2728 |
Gestational age < 37 wks |
isolated CHD: PA/VSD/ASD/TA/AVSD/TAPVC/other |
risk factor |
|
2729 |
Re-operation within admission |
isolated CHD: PA/VSD/ASD/TA/AVSD/TAPVC/other |
risk factor |
|
2737 |
logistic regression analysis and risk of mortality: Transformed age (days) |
isolated CHD: PA/VSD/ASD/TA/AVSD/TAPVC/other |
risk factor |
|
2739 |
logistic regression analysis and risk of mortality: RACHS score |
isolated CHD: PA/VSD/ASD/TA/AVSD/TAPVC/other |
risk factor |
|
2741 |
logistic regression analysis and risk of mortality: RACHS score(neonates≤30 days) |
isolated CHD: PA/VSD/ASD/TA/AVSD/TAPVC/other |
risk factor |
|
2742 |
logistic regression analysis and risk of mortality: RACHS score(Neonates, operations requiring CPB) |
isolated CHD: PA/VSD/ASD/TA/AVSD/TAPVC/other |
risk factor |
|
2753 |
PA/VSD(risk factors associated with redo PVR) |
isolated CHD/non-isolated CHD: TOF/PA, VSD/DORV/TGA/PS/other |
risk factor |
|
2754 |
Stentless(risk factors associated with redo PVR) |
isolated CHD/non-isolated CHD: TOF/PA, VSD/DORV/TGA/PS/other |
risk factor |
|
2766 |
LDL-cholesterol(cut off>3.3mmol/l)(association between maternal lipids and total homocysteine and CHD risk) |
NA: NA |
risk factor |
|
2767 |
Total/HDL-cholesterol(cut off>3.5 mmol/l)(association between maternal lipids and total homocysteine and CHD risk) |
NA: NA |
risk factor |
|
2768 |
Apolipoprotein B(cut off >85.0 mg/dl)(association between maternal lipids and total homocysteine and CHD risk) |
NA: NA |
risk factor |
|
2769 |
Apolipoprotein B/A-1 (cut off >0.6)(association between maternal lipids and total homocysteine and CHD risk) |
NA: NA |
risk factor |
|
2770 |
Total cholesterol (association between maternal lipids and total homocysteine as continuous variables and CHD risk) |
NA: NA |
risk factor |
|
2771 |
LDL-cholesterol (association between maternal lipids and total homocysteine as continuous variables and CHD risk) |
NA: NA |
risk factor |
|
2772 |
Apolipoprotein B (association between maternal lipids and total homocysteine as continuous variables and CHD risk) |
NA: NA |
risk factor |
|
2773 |
Apolipoprotein B/A-1 (association between maternal lipids and total homocysteine as continuous variables and CHD risk) |
NA: NA |
risk factor |
|
2784 |
Predictor indications of prolonger PICU) stay: Age ≤6 months |
isolated CHD/non-isolated CHD: AVSD/VSD/ASD/PAPVC/TAPVC/MR/PR/AR/AP window/TGA/DORV/TOF/CoA/TA, IAA/SPS/AS/PA/PA, VSD/SV/TGA, VSD |
risk factor |
|
2785 |
Predictor indications of prolonger PICU) stay: RACHS-1 category |
isolated CHD/non-isolated CHD: AVSD/VSD/ASD/PAPVC/TAPVC/MR/PR/AR/AP window/TGA/DORV/TOF/CoA/TA, IAA/SPS/AS/PA/PA, VSD/SV/TGA, VSD |
risk factor(Univariate analysis) |
|
2786 |
Predictor indications of prolonger PICU) stay: CPB time ≥78 min |
isolated CHD/non-isolated CHD: AVSD/VSD/ASD/PAPVC/TAPVC/MR/PR/AR/AP window/TGA/DORV/TOF/CoA/TA, IAA/SPS/AS/PA/PA, VSD/SV/TGA, VSD |
risk factor |
|
2787 |
Predictor indications of prolonger PICU) stay: NT-BNP preoperative ≥3.4 log |
isolated CHD/non-isolated CHD: AVSD/VSD/ASD/PAPVC/TAPVC/MR/PR/AR/AP window/TGA/DORV/TOF/CoA/TA, IAA/SPS/AS/PA/PA, VSD/SV/TGA, VSD |
risk factor |
|
2788 |
Predictor indications of prolonger PICU) stay: NT-BNP-peak ≥4.22 log |
isolated CHD/non-isolated CHD: AVSD/VSD/ASD/PAPVC/TAPVC/MR/PR/AR/AP window/TGA/DORV/TOF/CoA/TA, IAA/SPS/AS/PA/PA, VSD/SV/TGA, VSD |
risk factor |
|
2789 |
Predictor indications of prolonger PICU) stay: Troponine postoperative ≥4.4ng/ml |
isolated CHD/non-isolated CHD: AVSD/VSD/ASD/PAPVC/TAPVC/MR/PR/AR/AP window/TGA/DORV/TOF/CoA/TA, IAA/SPS/AS/PA/PA, VSD/SV/TGA, VSD |
risk factor |
|
2790 |
Predictor indications of prolonger PICU) stay: Postoperative lactate ≥3.4 mmolyl |
isolated CHD/non-isolated CHD: AVSD/VSD/ASD/PAPVC/TAPVC/MR/PR/AR/AP window/TGA/DORV/TOF/CoA/TA, IAA/SPS/AS/PA/PA, VSD/SV/TGA, VSD |
risk factor |
|
2840 |
relationship between fibrosis index and EDVi (end-diastolic volume index ) |
NA: NA |
risk factor(article mentioned) |
|
2841 |
relationship between fibrosis index and EF (ventricular ejection fraction) |
NA: NA |
risk factor(article mentioned) |
|
2845 |
age<2 years and relation with the need for reintervention |
isolated CHD/non-isolated CHD: TOF/TA/D-TGA/ASD/DORV/SVAS, BPAS/isolated BPAS |
risk factor(article mentioned) |
|
2846 |
diagnosis of TOF and relation with reintervention |
isolated CHD/non-isolated CHD: TOF/TA/D-TGA/ASD/DORV/SVAS, BPAS/isolated BPAS |
risk factor(article mentioned) |
|
2847 |
diagnosis of truncus arteriosus and relation with reintervention |
isolated CHD/non-isolated CHD: TOF/TA/D-TGA/ASD/DORV/SVAS, BPAS/isolated BPAS |
risk factor(article mentioned) |
|
2873 |
Postoperative TnT (ug l-1) |
isolated CHD/non-isolated CHD: AS, VSD/TCPC/PA, VSD/AVSD/PA, EA/DORV, VSD/PA, IVS/TAPVD/other |
risk factor |
|
2875 |
Temperature (℃) |
isolated CHD/non-isolated CHD: AS, VSD/TCPC/PA, VSD/AVSD/PA, EA/DORV, VSD/PA, IVS/TAPVD/other |
risk factor |
|
2877 |
Baseline characteristics: Twin pregnancy (%) |
NA: NA |
risk factor(article mentioned) |
|
2878 |
Residual lesions at conception: Pulmonary regurgitation ≥ grade II (%) |
NA: NA |
risk factor(article mentioned) |
|
2879 |
Residual lesions at conception: Branch pulmonary artery stenosis or occlusion (%) |
NA: NA |
risk factor(article mentioned) |
|
2895 |
balloon atrial septostomy (BAS) |
isolated CHD: TGA/SV |
risk factor |
|
2896 |
balloon atrial septostomy (BAS) |
isolated CHD: TGA/SV |
risk factor |
|
2954 |
BNP concentrations |
isolated CHD: TOF/SV/HRV |
risk factor |
|
2955 |
ANP concentrations |
isolated CHD: TOF/SV/HRV |
risk factor |
|
2963 |
higher plasma creatinine(mg/dL) |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/AC/TOF/TGA/ACHD |
risk factor |
|
2964 |
receiving diuretics(%) |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/AC/TOF/TGA/ACHD |
risk factor |
|
2966 |
prevalence of hyponatraemia in NYHA class |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/AC/TOF/TGA/ACHD |
risk factor |
|
2968 |
five-year death rate in hyponatraemia patients |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/AC/TOF/TGA/ACHD |
risk factor |
|
2969 |
relation between hyponatraemia and death |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/AC/TOF/TGA/ACHD |
risk factor |
|
2972 |
preoperative cyanosis |
isolated CHD/non-isolated CHD: ASD/VSD/PAPVC/p-AVSD/TGA, IVS/EA/CoA/VPS/SAS/SPS/AI/other |
risk factor |
|
2973 |
reoperation |
isolated CHD/non-isolated CHD: ASD/VSD/PAPVC/p-AVSD/TGA, IVS/EA/CoA/VPS/SAS/SPS/AI/other |
risk factor |
|
2974 |
length of ICU stay |
isolated CHD/non-isolated CHD: ASD/VSD/PAPVC/p-AVSD/TGA, IVS/EA/CoA/VPS/SAS/SPS/AI/other |
risk factor |
|
3004 |
Hematocrit |
NA: NA |
risk factor |
|
3005 |
Systolic blood pressure(SBP) at CICU admission |
NA: NA |
risk factor |
|
3006 |
Birth weight |
NA: NA |
risk factor |
|
3007 |
Intubation(after hemodilution on cardiopulmonary bypass) |
NA: NA |
risk factor |
|
3008 |
Systolic blood pressure(SBP) at CICU admission |
NA: NA |
risk factor |
|
3090 |
Older recipient age |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/AVC/other |
risk factor |
|
3091 |
Previous Fontan operation |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/AVC/other |
risk factor |
|
3092 |
Longer ischemic time |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/AVC/other |
risk factor |
|
3093 |
Interaction of donor age and ischemic time |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/AVC/other |
risk factor |
|
3094 |
Higher pre-Tx mean RAP (only in patients without previous Fontan) |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/AVC/other |
risk factor |
|
3095 |
Younger recipient age |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/AVC/other |
risk factor |
|
3096 |
Higher systolic transpulmonary gradient |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/AVC/other |
risk factor |
|
3097 |
cytomegalovirus+ donor, cytomegalovirus- recipient |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/AVC/other |
risk factor |
|
3098 |
Previous classical Glenn operation |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/AVC/other |
risk factor |
|
3111 |
correlation between marital status (single) and obstetric complications |
isolated CHD/non-isolated CHD: ASD/VSD/AVC/PS/PA, RV to PAC/DCRV, VSD/AS/AC/TOF/D-TGA, VSD, PS/ccTGA/SV/EA |
risk factor |
|
3112 |
correlation between nulliparity and obstetric complications |
isolated CHD/non-isolated CHD: ASD/VSD/AVC/PS/PA, RV to PAC/DCRV, VSD/AS/AC/TOF/D-TGA, VSD, PS/ccTGA/SV/EA |
risk factor |
|
3114 |
correlation between somking history and obstetric complications |
isolated CHD/non-isolated CHD: ASD/VSD/AVC/PS/PA, RV to PAC/DCRV, VSD/AS/AC/TOF/D-TGA, VSD, PS/ccTGA/SV/EA |
risk factor |
|
3115 |
correlation between nulliparity and obstetric complications |
isolated CHD/non-isolated CHD: ASD/VSD/AVC/PS/PA, RV to PAC/DCRV, VSD/AS/AC/TOF/D-TGA, VSD, PS/ccTGA/SV/EA |
risk factor |
|
3141 |
Neonatal asphyxia or hypoxia (yes/no) |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
risk factor |
|
3142 |
maternal upper respiratory infection (yes/no) |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
risk factor |
|
3143 |
number of previous pregnancies |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
risk factor |
|
3144 |
maternal infection (yes/no) |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
risk factor |
|
3145 |
maternal B-mode ultrasound examination (yes/no) |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
risk factor |
|
3146 |
maternal mental stress |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
risk factor |
|
3147 |
changes in respiratory rates/rhythms |
NA: NA |
risk factor |
|
3148 |
adventitious breath sounds |
NA: NA |
risk factor |
|
3149 |
sputum production |
NA: NA |
risk factor |
|
3151 |
having two or more indicators |
NA: NA |
risk factor |
|
3152 |
having two to four indicators |
NA: NA |
risk factor |
|
3153 |
CVL duration over 3 days |
isolated CHD: VSD/ASD/TOF/TGA |
risk factor |
|
3154 |
age < 28 days |
isolated CHD: VSD/ASD/TOF/TGA |
risk factor |
|
3176 |
combined with atrial fibrillation (AF) type of tachyarrhythmias |
isolated CHD/non-isolated CHD: TOF, PA/TOF/EA/UVH/TGA/PA/ccTGA |
risk factor |
|
3182 |
overall mortality rates |
NA: NA |
risk factor |
|
3183 |
mortality rates stratified by gender (girls) |
NA: NA |
risk factor |
|
3184 |
mortality rates stratified by age (more than 1 year old) |
NA: NA |
risk factor (crude OR) |
|
3185 |
mortality rates stratified by body weight (more than 5kg) |
NA: NA |
risk factor |
|
3186 |
mortality rates stratified by RACHS-1 (1 and 2) |
NA: NA |
risk factor |
|
3187 |
mortality rates stratified by CPB time (more than 60min) |
NA: NA |
risk factor |
|
3188 |
mortality rates stratified by Cyanosis (no-cyanosis) |
NA: NA |
risk factor |
|
3192 |
risk of IE with foreign material implantation undergoing cardiac catheter interventions |
isolated CHD/non-isolated CHD: BAV/MVP/VSD/AS/BAV, VSD, ASD/AV/AS, AI/TOF/PA, VSD, RPA/AVSD, PS |
risk factor |
|
3193 |
risk of IE with pacemaker implantation |
isolated CHD/non-isolated CHD: BAV/MVP/VSD/AS/BAV, VSD, ASD/AV/AS, AI/TOF/PA, VSD, RPA/AVSD, PS |
risk factor |
|
3194 |
risk of IE with pacemaker implantation |
isolated CHD/non-isolated CHD: BAV/MVP/VSD/AS/BAV, VSD, ASD/AV/AS, AI/TOF/PA, VSD, RPA/AVSD, PS |
risk factor |
|
3195 |
risk of IE with pacemaker implantation |
isolated CHD/non-isolated CHD: BAV/MVP/VSD/AS/BAV, VSD, ASD/AV/AS, AI/TOF/PA, VSD, RPA/AVSD, PS |
risk factor |
|
3211 |
correlation between cumulative mortality and GFR reduction |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/ccTGA/EA/ES/PA/other |
risk factor |
|
3212 |
correlation between cumulative mortality and GFR reduction |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/ccTGA/EA/ES/PA/other |
risk factor |
|
3213 |
correlation between 6-year cumulative mortality and GFR reduction |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/ccTGA/EA/ES/PA/other |
risk factor |
|
3214 |
correlation between moderate to severe impairment of GFR and mortality |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/ccTGA/EA/ES/PA/other |
risk factor |
|
3215 |
correlation between moderate to severe impairment of GFR and mortality |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/ccTGA/EA/ES/PA/other |
risk factor |
|
3216 |
correlation between NYHA class >2 and mortality |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/ccTGA/EA/ES/PA/other |
risk factor |
|
3217 |
correlation between systemic ventricular dysfunction and mortality |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/ccTGA/EA/ES/PA/other |
risk factor |
|
3218 |
correlation between previous palliative surgery and mortality |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/ccTGA/EA/ES/PA/other |
risk factor |
|
3231 |
association between Apgar score and CVP score after controlling for variables |
isolated CHD/non-isolated CHD: HLHS/HRHS/TA/DILV/DORV, MA/SILV/AA/AS, PS/AVC, PS/TOF/TGA/DORV/AVC/VSD/SASD/APVR/EA/PA/TVD/CoA/AS/IAA/RAI |
risk factor |
|
3232 |
association between mortality and CVP score after controlling for variables |
isolated CHD/non-isolated CHD: HLHS/HRHS/TA/DILV/DORV, MA/SILV/AA/AS, PS/AVC, PS/TOF/TGA/DORV/AVC/VSD/SASD/APVR/EA/PA/TVD/CoA/AS/IAA/RAI |
risk factor |
|
3233 |
association between mortality and hydrops (CVP category of ultrasound marker) |
isolated CHD/non-isolated CHD: HLHS/HRHS/TA/DILV/DORV, MA/SILV/AA/AS, PS/AVC, PS/TOF/TGA/DORV/AVC/VSD/SASD/APVR/EA/PA/TVD/CoA/AS/IAA/RAI |
risk factor |
|
3234 |
association between mortality and cardiomegaly with a heart to chest area ratio > 0.5 (CVP category of ultrasound marker) |
isolated CHD/non-isolated CHD: HLHS/HRHS/TA/DILV/DORV, MA/SILV/AA/AS, PS/AVC, PS/TOF/TGA/DORV/AVC/VSD/SASD/APVR/EA/PA/TVD/CoA/AS/IAA/RAI |
risk factor |
|
3242 |
age ( < 360 days) |
isolated CHD/non-isolated CHD: HLHS/VSD, PS/UVH, PS/PATR, TOF/UVH/CAT/CAT, IAA/VSD, ASDII/AVSD/VSD, ASD/TGA, AVSD, IAA/AVSD/IAA, VSD, ASD/HLHS/AVSD/TGA, PATR, VSD/TGA/VSD/AVSD/TAPVD/DORV/other |
risk factor |
|
3245 |
CPB duration > 90 min |
isolated CHD/non-isolated CHD: HLHS/VSD, PS/UVH, PS/PATR, TOF/UVH/CAT/CAT, IAA/VSD, ASDII/AVSD/VSD, ASD/TGA, AVSD, IAA/AVSD/IAA, VSD, ASD/HLHS/AVSD/TGA, PATR, VSD/TGA/VSD/AVSD/TAPVD/DORV/other |
risk factor |
|
3246 |
risk of postoperative JET |
isolated CHD/non-isolated CHD: HLHS/VSD, PS/UVH, PS/PATR, TOF/UVH/CAT/CAT, IAA/VSD, ASDII/AVSD/VSD, ASD/TGA, AVSD, IAA/AVSD/IAA, VSD, ASD/HLHS/AVSD/TGA, PATR, VSD/TGA/VSD/AVSD/TAPVD/DORV/other |
risk factor |
|
3247 |
CK-MB ( > 100μg/mL) |
isolated CHD/non-isolated CHD: HLHS/VSD, PS/UVH, PS/PATR, TOF/UVH/CAT/CAT, IAA/VSD, ASDII/AVSD/VSD, ASD/TGA, AVSD, IAA/AVSD/IAA, VSD, ASD/HLHS/AVSD/TGA, PATR, VSD/TGA/VSD/AVSD/TAPVD/DORV/other |
risk factor |
|
3251 |
age < 1 year |
isolated CHD/non-isolated CHD: VSD/VSD, ASD/VSD, PDA/MS/AS/CoA, VSD/CoA/ccTGA/EA/DORV/TOF/ccTGA/ASD/CAT/ccTGA, VSD, PS/TS, HRV, PS/AVAS/other |
risk factor |
|
3252 |
Cyanotic CHD |
isolated CHD/non-isolated CHD: VSD/VSD, ASD/VSD, PDA/MS/AS/CoA, VSD/CoA/ccTGA/EA/DORV/TOF/ccTGA/ASD/CAT/ccTGA, VSD, PS/TS, HRV, PS/AVAS/other |
risk factor |
|
3253 |
previous surgery for CHD |
isolated CHD/non-isolated CHD: VSD/VSD, ASD/VSD, PDA/MS/AS/CoA, VSD/CoA/ccTGA/EA/DORV/TOF/ccTGA/ASD/CAT/ccTGA, VSD, PS/TS, HRV, PS/AVAS/other |
risk factor |
|
3254 |
Perioperative IE |
isolated CHD/non-isolated CHD: VSD/VSD, ASD/VSD, PDA/MS/AS/CoA, VSD/CoA/ccTGA/EA/DORV/TOF/ccTGA/ASD/CAT/ccTGA, VSD, PS/TS, HRV, PS/AVAS/other |
risk factor |
|
3255 |
S.aureus as causative organism |
isolated CHD/non-isolated CHD: VSD/VSD, ASD/VSD, PDA/MS/AS/CoA, VSD/CoA/ccTGA/EA/DORV/TOF/ccTGA/ASD/CAT/ccTGA, VSD, PS/TS, HRV, PS/AVAS/other |
risk factor |
|
3256 |
Nosocomial IE |
isolated CHD/non-isolated CHD: VSD/VSD, ASD/VSD, PDA/MS/AS/CoA, VSD/CoA/ccTGA/EA/DORV/TOF/ccTGA/ASD/CAT/ccTGA, VSD, PS/TS, HRV, PS/AVAS/other |
risk factor |
|
3257 |
vegetation size >=15mm |
isolated CHD/non-isolated CHD: VSD/VSD, ASD/VSD, PDA/MS/AS/CoA, VSD/CoA/ccTGA/EA/DORV/TOF/ccTGA/ASD/CAT/ccTGA, VSD, PS/TS, HRV, PS/AVAS/other |
risk factor |
|
3258 |
vegetation size >=20mm |
isolated CHD/non-isolated CHD: VSD/VSD, ASD/VSD, PDA/MS/AS/CoA, VSD/CoA/ccTGA/EA/DORV/TOF/ccTGA/ASD/CAT/ccTGA, VSD, PS/TS, HRV, PS/AVAS/other |
risk factor |
|
3259 |
presence of HF |
isolated CHD/non-isolated CHD: VSD/VSD, ASD/VSD, PDA/MS/AS/CoA, VSD/CoA/ccTGA/EA/DORV/TOF/ccTGA/ASD/CAT/ccTGA, VSD, PS/TS, HRV, PS/AVAS/other |
risk factor |
|
3260 |
vegetation size >=20mm |
isolated CHD/non-isolated CHD: VSD/VSD, ASD/VSD, PDA/MS/AS/CoA, VSD/CoA/ccTGA/EA/DORV/TOF/ccTGA/ASD/CAT/ccTGA, VSD, PS/TS, HRV, PS/AVAS/other |
risk factor |
|
3261 |
age < 1 year |
isolated CHD/non-isolated CHD: VSD/VSD, ASD/VSD, PDA/MS/AS/CoA, VSD/CoA/ccTGA/EA/DORV/TOF/ccTGA/ASD/CAT/ccTGA, VSD, PS/TS, HRV, PS/AVAS/other |
risk factor |
|
3262 |
presence of HF |
isolated CHD/non-isolated CHD: VSD/VSD, ASD/VSD, PDA/MS/AS/CoA, VSD/CoA/ccTGA/EA/DORV/TOF/ccTGA/ASD/CAT/ccTGA, VSD, PS/TS, HRV, PS/AVAS/other |
risk factor |
|
3263 |
S.aureus as causative organism |
isolated CHD/non-isolated CHD: VSD/VSD, ASD/VSD, PDA/MS/AS/CoA, VSD/CoA/ccTGA/EA/DORV/TOF/ccTGA/ASD/CAT/ccTGA, VSD, PS/TS, HRV, PS/AVAS/other |
risk factor |
|
3266 |
RACHS-1 score=4-6 |
NA: NA |
risk factor |
|
3267 |
CPB time(min)>=90 |
NA: NA |
risk factor |
|
3299 |
Living independently from parents |
isolated CHD/non-isolated CHD: DOV/ES/SV/PA/TC/TA/LRAI/AVSD/CoA/EA/TOF/PI/PS/SVA/SAS/ASD/PDA |
risk factor |
|
3300 |
American Heart Association II as compared to III |
isolated CHD/non-isolated CHD: DOV/ES/SV/PA/TC/TA/LRAI/AVSD/CoA/EA/TOF/PI/PS/SVA/SAS/ASD/PDA |
risk factor |
|
3301 |
Symptoms on presentation |
isolated CHD/non-isolated CHD: DOV/ES/SV/PA/TC/TA/LRAI/AVSD/CoA/EA/TOF/PI/PS/SVA/SAS/ASD/PDA |
risk factor |
|
3302 |
Additional diagnosis made |
isolated CHD/non-isolated CHD: DOV/ES/SV/PA/TC/TA/LRAI/AVSD/CoA/EA/TOF/PI/PS/SVA/SAS/ASD/PDA |
risk factor |
|
3303 |
Lapse of medical care |
isolated CHD/non-isolated CHD: DOV/ES/SV/PA/TC/TA/LRAI/AVSD/CoA/EA/TOF/PI/PS/SVA/SAS/ASD/PDA |
risk factor |
|
3304 |
Symptoms on presentation |
isolated CHD/non-isolated CHD: DOV/ES/SV/PA/TC/TA/LRAI/AVSD/CoA/EA/TOF/PI/PS/SVA/SAS/ASD/PDA |
risk factor |
|
3305 |
Additional diagnosis made |
isolated CHD/non-isolated CHD: DOV/ES/SV/PA/TC/TA/LRAI/AVSD/CoA/EA/TOF/PI/PS/SVA/SAS/ASD/PDA |
risk factor |
|
3306 |
Additional diagnosis made |
isolated CHD/non-isolated CHD: DOV/ES/SV/PA/TC/TA/LRAI/AVSD/CoA/EA/TOF/PI/PS/SVA/SAS/ASD/PDA |
risk factor |
|
3307 |
American Heart Association II as compared to III |
isolated CHD/non-isolated CHD: DOV/ES/SV/PA/TC/TA/LRAI/AVSD/CoA/EA/TOF/PI/PS/SVA/SAS/ASD/PDA |
risk factor |
|
3309 |
age (months) (mean±SD) |
isolated CHD/non-isolated CHD: VSD/CAVSD/TOF/TGA, VSD/TGA, IVS/SV, DILV/SV, TA/TAPVC/AOR/ASD/VSD/PAVSD/PA, VSD/AOS/SV/VSD, CoA/TGA, VSD, LVOTO/ccTGA, VSD/ccTGA, VSD, LVOTO/ALCAPA/RVOTO, PS, AOS |
risk factor (article mentioned) |
|
3310 |
Body weight (mean±SD) |
isolated CHD/non-isolated CHD: VSD/CAVSD/TOF/TGA, VSD/TGA, IVS/SV, DILV/SV, TA/TAPVC/AOR/ASD/VSD/PAVSD/PA, VSD/AOS/SV/VSD, CoA/TGA, VSD, LVOTO/ccTGA, VSD/ccTGA, VSD, LVOTO/ALCAPA/RVOTO, PS, AOS |
risk factor (article mentioned) |
|
3311 |
Aristotle Basic Score |
isolated CHD/non-isolated CHD: VSD/CAVSD/TOF/TGA, VSD/TGA, IVS/SV, DILV/SV, TA/TAPVC/AOR/ASD/VSD/PAVSD/PA, VSD/AOS/SV/VSD, CoA/TGA, VSD, LVOTO/ccTGA, VSD/ccTGA, VSD, LVOTO/ALCAPA/RVOTO, PS, AOS |
risk factor (article mentioned) |
|
3312 |
CPB time |
isolated CHD/non-isolated CHD: VSD/CAVSD/TOF/TGA, VSD/TGA, IVS/SV, DILV/SV, TA/TAPVC/AOR/ASD/VSD/PAVSD/PA, VSD/AOS/SV/VSD, CoA/TGA, VSD, LVOTO/ccTGA, VSD/ccTGA, VSD, LVOTO/ALCAPA/RVOTO, PS, AOS |
risk factor (article mentioned) |
|
3313 |
Aortic crosslamp time |
isolated CHD/non-isolated CHD: VSD/CAVSD/TOF/TGA, VSD/TGA, IVS/SV, DILV/SV, TA/TAPVC/AOR/ASD/VSD/PAVSD/PA, VSD/AOS/SV/VSD, CoA/TGA, VSD, LVOTO/ccTGA, VSD/ccTGA, VSD, LVOTO/ALCAPA/RVOTO, PS, AOS |
risk factor (article mentioned) |
|
3314 |
IPPV(intermittent positive pressure ventilation) time (hour) |
isolated CHD/non-isolated CHD: VSD/CAVSD/TOF/TGA, VSD/TGA, IVS/SV, DILV/SV, TA/TAPVC/AOR/ASD/VSD/PAVSD/PA, VSD/AOS/SV/VSD, CoA/TGA, VSD, LVOTO/ccTGA, VSD/ccTGA, VSD, LVOTO/ALCAPA/RVOTO, PS, AOS |
risk factor (article mentioned) |
|
3315 |
ICU stay (days) |
isolated CHD/non-isolated CHD: VSD/CAVSD/TOF/TGA, VSD/TGA, IVS/SV, DILV/SV, TA/TAPVC/AOR/ASD/VSD/PAVSD/PA, VSD/AOS/SV/VSD, CoA/TGA, VSD, LVOTO/ccTGA, VSD/ccTGA, VSD, LVOTO/ALCAPA/RVOTO, PS, AOS |
risk factor (article mentioned) |
|
3389 |
NYHA functional class |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
risk factor |
|
3390 |
Antiarrhythmic therapy (excl.digoxin) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
risk factor |
|
3391 |
Antiarrhythmic therapy (incl.digoxin) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
risk factor |
|
3392 |
Amiodarone therapy |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
risk factor |
|
3393 |
Digoxin therapy |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
risk factor |
|
3395 |
Antiarrhythmic therapy (incl.digoxin) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
risk factor |
|
3396 |
NYHA functional class |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
risk factor |
|
3398 |
Amiodarone therapy |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
risk factor |
|
3399 |
NYHA functional class |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
risk factor |
|
3401 |
smoking behavior |
NA: NA |
risk factor (article mentioned) |
|
3402 |
Participation in sports |
NA: NA |
risk factor (article mentioned) |
|
3403 |
blood pressure (mmHg) |
NA: NA |
risk factor (article mentioned) |
|
3404 |
BMI (kg/m2) |
NA: NA |
risk factor (article mentioned) |
|
3405 |
no-smoking behavior |
NA: NA |
risk factor (article mentioned) |
|
3406 |
Participation in sports |
NA: NA |
risk factor (article mentioned) |
|
3407 |
high blood pressure |
NA: NA |
risk factor (article mentioned) |
|
3408 |
BMI (kg/m2) overweighted |
NA: NA |
risk factor (article mentioned) |
|
3409 |
Adolescent cohort |
NA: NA |
risk factor |
|
3411 |
Pediatric cardiac visits at least once per year |
NA: NA |
risk factor |
|
3412 |
Diagnosis with higher risk of early death |
NA: NA |
risk factor |
|
3413 |
Some activity restrictions |
NA: NA |
risk factor |
|
3414 |
physical health limitaions |
NA: NA |
risk factor |
|
3415 |
mental health problems |
NA: NA |
risk factor |
|
3416 |
role limitations because of physical and/or emotional problems |
NA: NA |
risk factor |
|
3417 |
fair or poor overall health status |
NA: NA |
risk factor |
|
3418 |
more pessimistic view of life and health |
NA: NA |
risk factor |
|
3419 |
increasing perceptions of risk for CHD complications |
NA: NA |
risk factor |
|
3420 |
increasing perceptions of risk from not attending follow-up appointments with cardiologist |
NA: NA |
risk factor |
|
3421 |
Diagnosis with higher risk of early death |
NA: NA |
risk factor |
|
3422 |
fair or poor overall health status |
NA: NA |
risk factor |
|
3423 |
increasing perception of risk for CHD complications |
NA: NA |
risk factor |
|
3443 |
Malnutrition |
NA: NA |
risk factor |
|
3445 |
TISS score: 7 days after admission |
NA: NA |
risk factor (article mentioned) |
|
3447 |
parenternal nutrition |
NA: NA |
risk factor |
|
3448 |
Candida colonization |
NA: NA |
risk factor |
|
3449 |
antibiotic treatment (any) |
NA: NA |
risk factor |
|
3450 |
antibiotic treatment (third-generation cephalosporins) |
NA: NA |
risk factor |
|
3451 |
antibiotic treatment (Glycopeptides) |
NA: NA |
risk factor |
|
3452 |
antibiotic treatment (Carbapenems) |
NA: NA |
risk factor |
|
3453 |
antibiotic treatment (Aminoglycosides) |
NA: NA |
risk factor |
|
3455 |
association between receipt of antibiotic treatment for more than 5 days and the acquistion of candidemia |
NA: NA |
risk factor |
|
3457 |
correlation between antibiotic treatment administered for more than 5 days and the risk of acquiring candidemia |
NA: NA |
risk factor |
|
3468 |
correlation between heart failure and patients with pacemaker |
isolated CHD/non-isolated CHD: TOF/D-TGA/SV/LTRS/AVD, PVD, CoA/other |
risk factor |
|
3469 |
correlation between chronotropic incompetence and patients with pacemaker |
isolated CHD/non-isolated CHD: TOF/D-TGA/SV/LTRS/AVD, PVD, CoA/other |
risk factor |
|
3491 |
risk for heart failure in patients with TOF |
isolated CHD/non-isolated CHD: LRS/TOF/D-TGA/SV/AVD, PVD/AC/other |
risk factor |
|
3492 |
risk for heart failure in patients with TGA (atrial diversion procedure |
isolated CHD/non-isolated CHD: LRS/TOF/D-TGA/SV/AVD, PVD/AC/other |
risk factor |
|
3493 |
risk for heart failure in patients with Single ventricle |
isolated CHD/non-isolated CHD: LRS/TOF/D-TGA/SV/AVD, PVD/AC/other |
risk factor |
|
3494 |
risk for heart failure in patients with miscellaneous |
isolated CHD/non-isolated CHD: LRS/TOF/D-TGA/SV/AVD, PVD/AC/other |
risk factor |
|
3495 |
risk for heart failure in patients with transanular patch |
isolated CHD/non-isolated CHD: LRS/TOF/D-TGA/SV/AVD, PVD/AC/other |
risk factor |
|
3496 |
risk for heart failure in patients with pulmonary valve replacement |
isolated CHD/non-isolated CHD: LRS/TOF/D-TGA/SV/AVD, PVD/AC/other |
risk factor |
|
3499 |
Age (yrs) |
isolated CHD/non-isolated CHD: VSD/TOF/ASD/PDA/SS/TA/PA, VSD/TAPVC/CoA/CAVC/PA, IVS/DORV/D-TGA/TA/other |
risk factor (article mentioned) |
|
3510 |
baseline NYHA class>=2 |
isolated CHD/non-isolated CHD: ASD/VSD/PS/PA, VSD/AS/TA/TOF/TGA/D-TGA, VSD/SV/EA |
risk factor |
|
3512 |
prior history of heart failure |
isolated CHD/non-isolated CHD: ASD/VSD/PS/PA, VSD/AS/TA/TOF/TGA/D-TGA, VSD/SV/EA |
risk factor |
|
3513 |
smoking history |
isolated CHD/non-isolated CHD: ASD/VSD/PS/PA, VSD/AS/TA/TOF/TGA/D-TGA, VSD/SV/EA |
risk factor |
|
3514 |
pulmonary regurgitation |
isolated CHD/non-isolated CHD: ASD/VSD/PS/PA, VSD/AS/TA/TOF/TGA/D-TGA, VSD/SV/EA |
risk factor |
|
3515 |
severe pulmonary regurgitation |
isolated CHD/non-isolated CHD: ASD/VSD/PS/PA, VSD/AS/TA/TOF/TGA/D-TGA, VSD/SV/EA |
risk factor |
|
3516 |
depressed subpulmonary ventricular EF |
isolated CHD/non-isolated CHD: ASD/VSD/PS/PA, VSD/AS/TA/TOF/TGA/D-TGA, VSD/SV/EA |
risk factor |
|
3517 |
depressed morphological right ventricular EF |
isolated CHD/non-isolated CHD: ASD/VSD/PS/PA, VSD/AS/TA/TOF/TGA/D-TGA, VSD/SV/EA |
risk factor |
|
3518 |
severe pulmonary regurgitation or depressed subpulmonary ventricular EF |
isolated CHD/non-isolated CHD: ASD/VSD/PS/PA, VSD/AS/TA/TOF/TGA/D-TGA, VSD/SV/EA |
risk factor |
|
3519 |
smoking history |
isolated CHD/non-isolated CHD: ASD/VSD/PS/PA, VSD/AS/TA/TOF/TGA/D-TGA, VSD/SV/EA |
risk factor |
|
3520 |
oxygen saturation per 1% decrease |
isolated CHD/non-isolated CHD: ASD/VSD/PS/PA, VSD/AS/TA/TOF/TGA/D-TGA, VSD/SV/EA |
risk factor |
|
3521 |
oxygen saturation per 1% decrease |
isolated CHD/non-isolated CHD: ASD/VSD/PS/PA, VSD/AS/TA/TOF/TGA/D-TGA, VSD/SV/EA |
risk factor |
|
3522 |
smoking history |
isolated CHD/non-isolated CHD: ASD/VSD/PS/PA, VSD/AS/TA/TOF/TGA/D-TGA, VSD/SV/EA |
risk factor |
|
3524 |
subaortic ventricular outflow tract gradient (gradient >30mmHg) |
isolated CHD/non-isolated CHD: ASD/VSD/PS/PA, VSD/AS/TA/TOF/TGA/D-TGA, VSD/SV/EA |
risk factor |
|
3525 |
symptomatic arrhythmia during pregnancy |
isolated CHD/non-isolated CHD: ASD/VSD/PS/PA, VSD/AS/TA/TOF/TGA/D-TGA, VSD/SV/EA |
risk factor |
|
3526 |
subaortic ventricular outflow tract gradient (gradient >30mmHg) |
isolated CHD/non-isolated CHD: ASD/VSD/PS/PA, VSD/AS/TA/TOF/TGA/D-TGA, VSD/SV/EA |
risk factor |
|
3528 |
cardiovascular compromise |
isolated CHD/non-isolated CHD: LHO/TGA/PA/SV/TAPVC/other |
risk factor |
|
3529 |
>=1 end organ dysfunctions |
isolated CHD/non-isolated CHD: LHO/TGA/PA/SV/TAPVC/other |
risk factor |
|
3530 |
admit age (days) |
isolated CHD/non-isolated CHD: LHO/TGA/PA/SV/TAPVC/other |
risk factor |
|
3531 |
CHD type: SV versus PA |
isolated CHD/non-isolated CHD: LHO/TGA/PA/SV/TAPVC/other |
risk factor |
|
3532 |
cardiovascular compromise |
isolated CHD/non-isolated CHD: LHO/TGA/PA/SV/TAPVC/other |
risk factor |
|
3533 |
CHD type: SV versus PA |
isolated CHD/non-isolated CHD: LHO/TGA/PA/SV/TAPVC/other |
risk factor |
|
3537 |
age (years) |
isolated CHD/non-isolated CHD: VSD/ASD/TOF/AV/AVC/AS/RVOTO/CoA/PDA/other |
risk factor(article mentioned) |
|
3538 |
inotropic score (μg/kg/min) |
isolated CHD/non-isolated CHD: VSD/ASD/TOF/AV/AVC/AS/RVOTO/CoA/PDA/other |
risk factor(article mentioned) |
|
3539 |
ischemic time (min) |
isolated CHD/non-isolated CHD: VSD/ASD/TOF/AV/AVC/AS/RVOTO/CoA/PDA/other |
risk factor(article mentioned) |
|
3540 |
CBP time (min) |
isolated CHD/non-isolated CHD: VSD/ASD/TOF/AV/AVC/AS/RVOTO/CoA/PDA/other |
risk factor(article mentioned) |
|
3541 |
Clamp time (min) |
isolated CHD/non-isolated CHD: VSD/ASD/TOF/AV/AVC/AS/RVOTO/CoA/PDA/other |
risk factor(article mentioned) |
|
3671 |
Duration of TPN (total parenteral nutrition), d (mean ± SD) |
non-isolated CHD: TGV, PDA, PFO, VSD, CoA/PDA, TGV, VSD, DORV/CoA, LVH/RVH, SV, TGV, CoA, VSD/HLHS, AA, PDA/TOF, TAPVR, ASD |
risk factor (article mentioned) |
|
3672 |
Duration of antibiotics, d (mean ± SD) |
non-isolated CHD: TGV, PDA, PFO, VSD, CoA/PDA, TGV, VSD, DORV/CoA, LVH/RVH, SV, TGV, CoA, VSD/HLHS, AA, PDA/TOF, TAPVR, ASD |
risk factor (article mentioned) |
|
3673 |
Bypass time (min) |
non-isolated CHD: TGV, PDA, PFO, VSD, CoA/PDA, TGV, VSD, DORV/CoA, LVH/RVH, SV, TGV, CoA, VSD/HLHS, AA, PDA/TOF, TAPVR, ASD |
risk factor (article mentioned) |
|
3674 |
Clinical signs and presence of thrombus |
non-isolated CHD: TGV, PDA, PFO, VSD, CoA/PDA, TGV, VSD, DORV/CoA, LVH/RVH, SV, TGV, CoA, VSD/HLHS, AA, PDA/TOF, TAPVR, ASD |
risk factor (article mentioned) |
|
3691 |
female patients |
isolated CHD/non-isolated CHD: LTRS/TOF/TOF, PA/VSD, PS/TGA/APVR/LVOTO |
risk factor (article mentioned) |
|
3693 |
warfarin |
isolated CHD/non-isolated CHD: LTRS/TOF/TOF, PA/VSD, PS/TGA/APVR/LVOTO |
risk factor (article mentioned) |
|
3706 |
factors affecting late mortality: gender |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, PS, VSD/TGA, PA/TGA, PS/TA, PA/PA, VSD/PA, IVS/DORV, VSD/DORV, PS/DORV, VSD, PS/TOF/TGA/TA/UVH/other |
risk factor (article mentioned) |
|
3707 |
factors affecting late mortality: age at conduit operation |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, PS, VSD/TGA, PA/TGA, PS/TA, PA/PA, VSD/PA, IVS/DORV, VSD/DORV, PS/DORV, VSD, PS/TOF/TGA/TA/UVH/other |
risk factor (article mentioned) |
|
3708 |
factors affecting late mortality: age at conduit operation |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, PS, VSD/TGA, PA/TGA, PS/TA, PA/PA, VSD/PA, IVS/DORV, VSD/DORV, PS/DORV, VSD, PS/TOF/TGA/TA/UVH/other |
risk factor (article mentioned) |
|
3709 |
factors affecting late mortality: diagnosis of TGA |
isolated CHD/non-isolated CHD: TGA/PA, TOF |
risk factor (article mentioned) |
|
3710 |
factors affecting late mortality: diagnosis of TA |
isolated CHD/non-isolated CHD: TGA/PA, TOF |
risk factor (article mentioned) |
|
3711 |
factors affecting late mortality: diagnosis of corrected TGA |
isolated CHD/non-isolated CHD: TGA/PA, TOF |
risk factor (article mentioned) |
|
3712 |
factors affecting late mortality: diagnosis of univentricular heart |
isolated CHD/non-isolated CHD: TGA/PA, TOF |
risk factor (article mentioned) |
|
3713 |
pulmonary ventricle/systemic ventricle ratio |
isolated CHD/non-isolated CHD: TGA/PA, TOF |
risk factor (article mentioned) |
|
3716 |
risk factors for conduit failure: conduit size |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, PS, VSD/TGA, PA/TGA, PS/TA, PA/PA, VSD/PA, IVS/DORV, VSD/DORV, PS/DORV, VSD, PS/TOF/TGA/TA/UVH/other |
risk factor (article mentioned) |
|
3717 |
risk factors for conduit failure: conduit size |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, PS, VSD/TGA, PA/TGA, PS/TA, PA/PA, VSD/PA, IVS/DORV, VSD/DORV, PS/DORV, VSD, PS/TOF/TGA/TA/UVH/other |
risk factor (article mentioned) |
|
3718 |
risk factors for conduit failure: conduit size |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, PS, VSD/TGA, PA/TGA, PS/TA, PA/PA, VSD/PA, IVS/DORV, VSD/DORV, PS/DORV, VSD, PS/TOF/TGA/TA/UVH/other |
risk factor (article mentioned) |
|
3719 |
risk factors for Conduit failure: diagnosis of TGA |
isolated CHD/non-isolated CHD: TGA/PA, TOF |
risk factor (article mentioned) |
|
3720 |
risk factors for conduit failure: type of prosthsis: homograft |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, PS, VSD/TGA, PA/TGA, PS/TA, PA/PA, VSD/PA, IVS/DORV, VSD/DORV, PS/DORV, VSD, PS/TOF/TGA/TA/UVH/other |
risk factor (article mentioned) |
|
3721 |
Mean age at listing (years) |
isolated CHD/non-isolated CHD: PA, IVS/TA/TA/TS/HLHS/PA, VSD/TC/LSOD/ASD/CACA/TA/ECD/TOF/other |
risk factor (article mentioned) |
|
3722 |
Median age at listing (years) |
isolated CHD/non-isolated CHD: PA, IVS/TA/TA/TS/HLHS/PA, VSD/TC/LSOD/ASD/CACA/TA/ECD/TOF/other |
risk factor (article mentioned) |
|
3724 |
Onset of heart failure to listing (months) |
isolated CHD/non-isolated CHD: PA, IVS/TA/TA/TS/HLHS/PA, VSD/TC/LSOD/ASD/CACA/TA/ECD/TOF/other |
risk factor (article mentioned) |
|
3739 |
overall mean vessel diameter |
isolated CHD: TOF/PA/CBPS/TR |
risk factor (article mentioned) |
|
3764 |
Functionally univentricular cardiac anomaly |
isolated CHD/non-isolated CHD: TOF/CoA, IAA/TA, AP window/TGA/SV/HLHS/SV, AAO/PS/TOF, PA/APV |
risk factor |
|
3765 |
Univentricular anomaly with arch obstruction |
isolated CHD/non-isolated CHD: TOF/CoA, IAA/TA, AP window/TGA/SV/HLHS/SV, AAO/PS/TOF, PA/APV |
risk factor |
|
3766 |
HLHS |
isolated CHD: HLHS |
risk factor |
|
3767 |
TA/AP W |
non-isolated CHD: TA/AP window |
risk factor |
|
3769 |
Prematurity(<36 weeks) |
isolated CHD/non-isolated CHD: TOF/CoA, IAA/TA, AP window/TGA/SV/HLHS/SV, AAO/PS/TOF, PA/APV |
risk factor |
|
3770 |
neonatal clinical variables: Episode of low cardiac output or shock |
isolated CHD/non-isolated CHD: TOF/CoA, IAA/TA, AP window/TGA/SV/HLHS/SV, AAO/PS/TOF, PA/APV |
risk factor |
|
3771 |
neonatal clinical variables: Highest prostaglandin dose 0.05 g/kg/min |
isolated CHD/non-isolated CHD: TOF/CoA, IAA/TA, AP window/TGA/SV/HLHS/SV, AAO/PS/TOF, PA/APV |
risk factor |
|
3772 |
risk of death in different stage number of NEC patients |
isolated CHD/non-isolated CHD: TOF/CoA, IAA/TA, AP window/TGA/SV/HLHS/SV, AAO/PS/TOF, PA/APV |
risk factor |
|
3831 |
nonurban location |
isolated CHD: AS/ASD/TOF |
risk factor (article mentioned) |
|
3832 |
nonurban location |
isolated CHD: AS/ASD/TOF |
risk factor (article mentioned) |
|
3833 |
lesions: valvular aortic stenosis |
isolated CHD: AS/ASD/TOF |
risk factor (article mentioned) |
|
3834 |
lesions: tetralogy of Fallot |
isolated CHD: AS/ASD/TOF |
risk factor (article mentioned) |
|
3835 |
insurance |
isolated CHD: AS/ASD/TOF |
risk factor (article mentioned) |
|
3839 |
preoperative pulmonary hypertension |
isolated CHD: TAPVC/TGA/VSD/HLHS/TA/AVC |
risk factor |
|
3840 |
absence of mixed venous saturation monitoring |
isolated CHD: TAPVC/TGA/VSD/HLHS/TA/AVC |
risk factor(article mentioned) |
|
3841 |
absence of prophylactic alpha-blockade |
isolated CHD: TAPVC/TGA/VSD/HLHS/TA/AVC |
risk factor(article mentioned) |
|
3842 |
postoperative pulmonary hypertension |
isolated CHD: TAPVC/TGA/VSD/HLHS/TA/AVC |
risk factor |
|
3921 |
Immunocompromised |
isolated CHD/non-isolated CHD: TA/TOF/PA, IVS/D-TGA/PS/D-TGA, DORV |
risk factor |
|
3943 |
association with sex and dental health behaviours(brush teeth 2 times/day) |
NA: NA |
risk factor |
|
3944 |
association with education status and dental health behaviours(brush teeth 2 times/day) |
NA: NA |
risk factor |
|
3948 |
association with sports participation with married status |
NA: NA |
risk factor |
|
3949 |
association between sports participation with education |
NA: NA |
risk factor |
|
3950 |
association between sports participation with employment |
NA: NA |
risk factor |
|
3953 |
<37 week gestation |
isolated CHD: SV dd-SBF/BiV dd-SBF/D-TGA/BiV dd-PBF/SV dd-PBF/SV/TA/other |
risk factor |
|
3954 |
Feeds>100 ml/kg/d |
isolated CHD: SV dd-SBF/BiV dd-SBF/D-TGA/BiV dd-PBF/SV dd-PBF/SV/TA/other |
risk factor |
|
3956 |
cardiac lesion of BiV dd-PBF(ductal-dependent pulmonary perfusion) |
isolated CHD: BiV dd-PBF |
risk factor |
|
3973 |
relative average miRNA-208 expression in children with oxygen saturation below 90% |
NA: VSD, ASD/AVC/TGA/TOF/CoA/RV to PAC |
risk factor |
|
3996 |
maternal upper respiratory tract infection/ influenza during early pregnancy with CHD in offspring |
isolated CHD/non-isolated CHD: NA/VSD/TOF |
risk factor |
|
3997 |
maternal upper respiratory tract infection/ influenza during early pregnancy with simple CHD in offspring |
isolated CHD: NA |
risk factor |
|
3998 |
maternal upper respiratory tract infection/ influenza during early pregnancy with VSD in offspring |
isolated CHD: VSD |
risk factor |
|
3999 |
\maternal upper respiratory tract infection/ influenza during early pregnancy with complex CHD in offspring |
non-isolated CHD: NA |
risk factor |
|
4000 |
maternal upper respiratory tract infection/ influenza during early pregnancy with TOF in offspring |
isolated CHD: TOF |
risk factor |
|
4019 |
NLRP3(nucleotide-binding oligomerization domain-like (NOD)-like receptor protein 3) |
NA: NA |
risk factor |
|
4020 |
HMGB1(high-mobility group box 1) |
NA: NA |
risk factor |
|
4036 |
Modified Ross score |
isolated CHD: PDA/VSD/DORV/ASD/p-AVSD/PAPVR |
risk factor |
|
4038 |
OER(Oxygen extraction rate) |
isolated CHD: PDA/VSD/DORV/ASD/p-AVSD/PAPVR |
risk factor |
|
4060 |
assocciated factors with ASD: women |
isolated CHD: ASD |
risk factor |
|
4061 |
assocciated factors with ASD: age(10-19 years) |
isolated CHD: ASD |
risk factor |
|
4062 |
assocciated factors with ASD: age(20-39 years) |
isolated CHD: ASD |
risk factor |
|
4063 |
assocciated factors with ASD: age(>40 years) |
isolated CHD: ASD |
risk factor |
|
4068 |
obese |
NA: NA |
risk factor |
|
4069 |
overweight |
NA: NA |
risk factor |
|
4073 |
Post-operative infection |
NA: NA |
risk factor |
|
4079 |
BMI(<5th percentile)(infants) |
NA: NA |
risk factor |
|
4081 |
STS(Society of Thoracic Surgeons) risk grade(infants) |
NA: NA |
risk factor |
|
4082 |
Delayed sternal closure(infants) |
NA: NA |
risk factor |
|
4083 |
serum creatinine(>cut off value)(infants) |
NA: NA |
risk factor |
|
4085 |
Neutrophil count(>cut off value)(infants) |
NA: NA |
risk factor |
|
4086 |
Lymphocytes/WBC(
|
NA: NA |
risk factor |
|
|
4089 |
Neutrophils/WBC(>cut off value)(infants) |
NA: NA |
risk factor |
|
4092 |
history of cardiac surgery(children) |
NA: NA |
risk factor |
|
4093 |
BMI(<5th percentile)(children) |
NA: NA |
risk factor |
|
4094 |
STS(Society of Thoracic Surgeons) risk grade(children) |
NA: NA |
risk factor |
|
4095 |
Delayed sternal closure(children) |
NA: NA |
risk factor |
|
4097 |
Lymphocyte count(
|
NA: NA |
risk factor |
|
|
4099 |
Lymphocytes/WBC(
|
NA: NA |
risk factor |
|
|
4101 |
Neutrophil count(>cut off value)(children) |
NA: NA |
risk factor |
|
4102 |
Neutrophils/WBC(>cut off value)(children) |
NA: NA |
risk factor |
|
4103 |
ALT(>cut off value)(children) |
NA: NA |
risk factor |
|
4104 |
AST(>cut off value)(children) |
NA: NA |
risk factor |
|
4105 |
prevalence of CHD in different sex |
isolated CHD: ASD/VSD/PDA/BAV/TOF/PS/AVSD/TGA/EA/other |
risk factor |
|
4106 |
prevalence of CHD in different maternal age |
isolated CHD: ASD/VSD/PDA/BAV/TOF/PS/AVSD/TGA/EA/other |
risk factor |
|
4107 |
prevalence of CHD in different gestation age |
isolated CHD: ASD/VSD/PDA/BAV/TOF/PS/AVSD/TGA/EA/other |
risk factor |
|
4108 |
prevalence of CHD in different birthweight(g) |
isolated CHD: ASD/VSD/PDA/BAV/TOF/PS/AVSD/TGA/EA/other |
risk factor |
|
4116 |
maternal education level(low:compulsory only) |
isolated CHD/non-isolated CHD: anomalies of the venous return/ASD/AVSD, OPD/AVC/HLHS/VSD/TOF, TGA/CoA/CACA |
risk factor |
|
4117 |
Pregestational Diabetes |
isolated CHD/non-isolated CHD: anomalies of the venous return/ASD/AVSD, OPD/AVC/HLHS/VSD/TOF, TGA/CoA/CACA |
risk factor |
|
4118 |
Poor diet(low fruit & vegetable) |
isolated CHD/non-isolated CHD: anomalies of the venous return/ASD/AVSD, OPD/AVC/HLHS/VSD/TOF, TGA/CoA/CACA |
risk factor |
|
4120 |
Fizzy or high energy every day |
isolated CHD/non-isolated CHD: anomalies of the venous return/ASD/AVSD, OPD/AVC/HLHS/VSD/TOF, TGA/CoA/CACA |
risk factor |
|
4121 |
Pregnancy-related stress |
isolated CHD/non-isolated CHD: anomalies of the venous return/ASD/AVSD, OPD/AVC/HLHS/VSD/TOF, TGA/CoA/CACA |
risk factor |
|
4122 |
Multiple stress events >3 |
isolated CHD/non-isolated CHD: anomalies of the venous return/ASD/AVSD, OPD/AVC/HLHS/VSD/TOF, TGA/CoA/CACA |
risk factor |
|
4123 |
Self-reported maternal clotting disorder |
isolated CHD/non-isolated CHD: anomalies of the venous return/ASD/AVSD, OPD/AVC/HLHS/VSD/TOF, TGA/CoA/CACA |
risk factor |
|
4124 |
Prescriptions in the first three months of pregnancy of the anti-clotting medication enoxaparin |
isolated CHD/non-isolated CHD: anomalies of the venous return/ASD/AVSD, OPD/AVC/HLHS/VSD/TOF, TGA/CoA/CACA |
risk factor |
|
4125 |
Prescriptions in the first three months of pregnancy of the anti-clotting medication aspirin |
isolated CHD/non-isolated CHD: anomalies of the venous return/ASD/AVSD, OPD/AVC/HLHS/VSD/TOF, TGA/CoA/CACA |
risk factor |
|
4126 |
Paternal raised blood pressure |
isolated CHD/non-isolated CHD: anomalies of the venous return/ASD/AVSD, OPD/AVC/HLHS/VSD/TOF, TGA/CoA/CACA |
risk factor |
|
4127 |
Vaginal infection/thrush |
isolated CHD/non-isolated CHD: anomalies of the venous return/ASD/AVSD, OPD/AVC/HLHS/VSD/TOF, TGA/CoA/CACA |
risk factor |
|
4129 |
BMI(<5th percentile) |
NA: NA |
risk factor |
|
4131 |
aortic shunt(left-to-right) |
NA: NA |
risk factor |
|
4132 |
aortic shunt(right-to-left) |
NA: NA |
risk factor |
|
4133 |
aortic shunt(Bi-directional) |
NA: NA |
risk factor |
|
4135 |
atrial shunt(left-to-right) |
NA: NA |
risk factor |
|
4136 |
atrial shunt(right-to-left) |
NA: NA |
risk factor |
|
4137 |
atrial shunt(Bi-directional) |
NA: NA |
risk factor |
|
4141 |
ventricular level shunt(Bi-directional) |
NA: NA |
risk factor |
|
4142 |
Aortic Insufficiency(AI)(minimal) |
NA: NA |
risk factor |
|
4144 |
Tricuspid Regurgitation(TR)(minimal) |
NA: NA |
risk factor |
|
4145 |
with mitral insufficiency(MI) |
NA: NA |
risk factor |
|
4146 |
History of cardiac surgery |
NA: NA |
risk factor |
|
4147 |
RACHS-1 risk grade 1 |
NA: NA |
risk factor |
|
4150 |
selective extracorporeal surgery |
NA: NA |
risk factor |
|
4151 |
emergency extracorporeal surgery |
NA: NA |
risk factor |
|
4153 |
circulating temperature(mild hypothemia) |
NA: NA |
risk factor |
|
4154 |
circulating temperature(deep hypothemia) |
NA: NA |
risk factor |
|
4155 |
circulating temperature(middle and low temperature) |
NA: NA |
risk factor |
|
4156 |
circulation method(low folw cycle) |
NA: NA |
risk factor |
|
4157 |
circulation method(cerebral perfusion) |
NA: NA |
risk factor |
|
4158 |
circulation method(Circulatory arrest) |
NA: NA |
risk factor |
|
4162 |
myocardial preservation(Cold blood cardioplegia (4:1)) |
NA: NA |
risk factor |
|
4163 |
with residual shunt |
NA: NA |
risk factor |
|
4164 |
with LVOTO |
NA: NA |
risk factor |
|
4165 |
with RVOTO |
NA: NA |
risk factor |
|
4166 |
postoperative rhythm of the heart(III° AVB) |
NA: NA |
risk factor |
|
4167 |
postoperative rhythm of the heart(II° AVB) |
NA: NA |
risk factor |
|
4172 |
Relative mortality risk after pulmonary valve replacement(age brackets of 40–45) |
isolated CHD: TOF |
risk factor |
|
4182 |
risk of PTB |
isolated CHD: NA |
risk factor |
|
4183 |
risk of SGA |
isolated CHD: NA |
risk factor |
|
4186 |
risk of preterm birth of different age(35-39 years) |
isolated CHD: NA |
risk factor |
|
4187 |
risk of preterm birth of different age(40-44 years) |
isolated CHD: NA |
risk factor |
|
4190 |
risk of preterm birth to SGA of different age(35-39 years) |
isolated CHD: NA |
risk factor |
|
4191 |
risk of preterm birth to SGA of different age(40-44 years) |
isolated CHD: NA |
risk factor |
|
4192 |
higher risk of PTB at maternal age(35-39 years) |
isolated CHD: NA |
risk factor |
|
4193 |
higher risk of PTB at maternal age(40-44 years) |
isolated CHD: NA |
risk factor |
|
4198 |
with JET |
isolated CHD: AVSD/TOF/VSD |
risk factor |
|
4227 |
Maternal vitamin D receptor gene Fok1 genotype: F/f |
isolated CHD: VSD/ASD/PDA/TGA/TOF/TAS/HLHS/DORV |
risk factor |
|
4228 |
Maternal vitamin D receptor gene Fok1 genotype: f/f |
isolated CHD: VSD/ASD/PDA/TGA/TOF/TAS/HLHS/DORV |
risk factor |
|
4229 |
Maternal vitamin D receptor gene Fok1 alleles: f |
isolated CHD: VSD/ASD/PDA/TGA/TOF/TAS/HLHS/DORV |
risk factor |
